Mcl-1
January 31, 2020
SENESCENCE-ASSOCIATED BETA-GALACTOSIDASE (SA-Β-GAL OR SABG)
February 10, 2020
Neuroprotective effects of flavonoids and polyphenols
- A berry thought-provoking idea: the potential role of plant polyphenols in the treatment of age-related cognitive disorders
- A bird’s-eye view of the multiple biochemical mechanisms that propel pathology of Alzheimer’s disease: recent advances and mechanistic perspectives on …
- A blueberry extract-supplemented diet rescues phenotypes in drosophila melanogaster models of parkinson disease
- A Comparative Study on the Phenolic Composition and Biological Activities of Morus alba L. Commercial Samples
- A Comparison of the Antioxidant Activity with the Total Phenolic and Total flavonoid contents of the Leaves and Stem-bark of Anogeissus leiocarpa (DC.) Guill& Pirr …
- A comprehensive database and analysis framework to incorporate multiscale data types and enable integrated analysis of bioactive polyphenols
- A comprehensive review on phytochemistry, pharmacology, and flavonoid biosynthesis of Scutellaria baicalensis
- A Current Understanding of Alzheimer’s Disease and the Prospects of Phytopharmacological Intervention as a Management Strategy
- A meta-analysis of tea drinking and risk of Parkinson’s disease
- A molecular approach in drug development for Alzheimer’s disease
- A Narrative Review of Lifestyle Factors Associated with Parkinson’s Disease Risk and Progression
- A Novel GSK3β Inhibitor Reduces Tau Pathology in Alzheimer’s Disease
- A Paradigm Shift to Prevent and Treat Alzheimer’s Disease: From Monotargeting Pharmaceuticals to Pleiotropic Plant Polyphenols
- A pharmacological appraisal of neuroprotective and neurorestorative flavonoids against Neurodegenerative diseases
- A review of antioxidant and pharmacological properties of phenolic compounds in Acacia confusa
- A Review of Antioxidants and Alzheimer
- A review of antioxidants and Alzheimer’s disease
- A review of genome mutation and Alzheimer’s disease
- A review on cholinesterase inhibitors for Alzheimer’s disease
- A Review on Current Strategies and Future Perspective in Respect to Alzheimer’s Disease Treatment
- A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer’s and Parkinson’s diseases
- A Review on Medicinal Plants for Alzheimer’s disease
- A review on mitochondrial restorative mechanism of antioxidants in Alzheimer’s disease and other neurological conditions
- A review on potential mechanisms of Terminalia chebula in Alzheimer’s disease
- A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer’s disease
- A review on the beneficial effects of tea polyphenols on human health
- A review on the status of the phenolic compounds and antioxidant capacity of the flour: Effects of cereal processing
- A review–probable mechanism of action of curcumin for the treatment of Alzheimer disease (AD)
- A review: inflammatory process in Alzheimer’s disease, role of cytokines
- A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model
- A Study on the Role of Mimosa Pudica (Thottar Chinungi) on the Experimental Models of Parkinsonism (Nadukku Vatham)
- A synopsis on the linkage between age-related dementias and vascular disorders
- A systematic review on the role of natural products in modulating the pathways in Alzheimer’s disease
- Acacetin—A simple flavone exhibiting diverse pharmacological activities
- Accumulation of citrus flavanones in bovine milk following citrus pulp incorporation into the diet of dairy cows
- Acetyl-cholinesterase Inhibition by Extracts and Isolated Flavones from Linaria reflexa Desf. (Scrophulariaceae)
- Acetylated flavonoid Glycosides Potentiating NGF Action from Scoparia dulcis
- Activation of pro‐survival Akt and ERK1/2 signalling pathways underlie the anti‐apoptotic effects of flavanones in cortical neurons
- Acute effects of flavonoid-rich blueberry on cognitive and vascular function in healthy older adults
- Adult‐onset brain tumors and neurodegeneration: Are polyphenols protective?
- Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer’s disease
- Advances in multi-functional ligands and the need for metal-related pharmacology for the management of Alzheimer disease
- Advances in research on active constituents of Chinese materia medica in treatment of Alzheimer’s disease [J]
- Agathisflavone, a flavonoid derived from Poincianella pyramidalis (Tul.), enhances neuronal population and protects against glutamate excitotoxicity
- Age-related cognitive impairment as a sign of geriatric neurocardiovascular interactions: may polyphenols play a protective role?
- Aging risk factors and Parkinson’s disease: contrasting roles of common dietary constituents
- Alcohol Consumption in Predementia and dementia Syndromes
- Alcohol intake and risk of dementia
- Alcohol, wine and mental health: focus on dementia and stroke
- Alcoholic beverages and incidence of dementia: 34-year follow-up of the prospective population study of women in Göteborg
- Almond, hazelnut and walnut, three nuts for neuroprotection in Alzheimer’s disease: A neuropharmacological review of their bioactive constituents
- Alpha-secretase ADAM10 regulation: insights into Alzheimer’s disease treatment
- Alpha-Synuclein and synuceinopathies as related to Parkinson’s disease
- Alpha-synuclein oligomers—neurotoxic molecules in Parkinson’s disease and other Lewy body disorders
- Altered Micro-RNA Regulation and Neuroprotection Activity of Eremostachys labiosiformis in Alzheimer’s Disease Model
- Alzheimer’s and Parkinson’s Disease Novel Therapeutic Target: The Mitochondrial Pyruvate Carrier-Ligand Docking to Screen Natural Compounds Related to Classic …
- Alzheimer’s Dementia: Can It Be Prevented?
- Alzheimer’s disease (AD) genes: Enrichment in cancer genes and those related to comorbid conditions, risk factors (pollution and pathogens) or beneficial agents …
- Alzheimer’s Disease & Treatment
- Alzheimer’s Disease & Treatment
- Alzheimer’s Disease & Treatment
- Alzheimer’s Disease & Treatment, Vol. 1
- Alzheimer’s disease and antioxidant therapy: how long how far?
- Alzheimer’s disease and its current treatments; Is there a possibility for a cure
- Alzheimer’s Disease and Metal Contamination: Aspects on Genotoxicity
- Alzheimer’s disease and natural products: Future regimens emerging from nature
- Alzheimer’s disease and other Neurodegenerative disorders
- Alzheimer’s Disease and Oxidative Stress
- Alzheimer’s Disease and Parkinson’s Disease: A Nutritional Toxicology Perspective of the Impact of Oxidative Stress, Mitochondrial Dysfunction, Nutrigenomics and …
- Alzheimer’s Disease and the Main Aspects-Literature Review
- Alzheimer’s DISEASE AND THE MICROBIOME
- Alzheimer’s disease as oligomeropathy
- Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
- Alzheimer’s Disease Theranostics
- Alzheimer’s disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
- Alzheimer’s Disease, Drosophila melanogaster and Polyphenols
- Alzheimer’s disease, neuroinflammation and the influence of different combinations of nutrients
- Alzheimer’s disease: A challenge in managing with certain medicinal plants-Areview
- Alzheimer’s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL …
- Alzheimer’s Disease: An Approach for Non-Pharmacological Therapies
- Alzheimer’s disease: biological aspects, therapeutic perspectives and diagnostic tools
- Alzheimer’s Disease: Early Diagnosis & Fundamental Therapeutics
- Alzheimer’s disease: from pathology to therapeutic approaches
- Alzheimer’s disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms
- Alzheimer’s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the …
- Alzheimers Disease & Parkinsonism
- Ameliorating effect of ethanol leaf extract of Ficus hispida Linn. on amyloid beta Aβ (25-35) induced cognitive deficits and oxidative stress in Alzheimer’s mice
- Amelioration of 6-Hydroxydopamine-Lesion Induced Neurotoxicity by Different Extracts of Ocimum sanctum Leaves in Rodent Model of Parkinson’s Disease
- Amelioration of cognitive impairment and neurodegeneration by catechin hydrate in rat model of streptozotocin-induced experimental dementia of Alzheimer’s type
- Amentoflavone Ameliorates Aβ1–42-Induced Memory Deficits and oxidative stress in Cellular and Rat Model
- Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson’s disease model mice through PI3K/Akt and ERK signaling pathways
- Amentoflavone suppresses amyloid β1–42 neurotoxicity in Alzheimer’s disease through the inhibition of pyroptosis
- AMP‐activated protein kinase: a potential player in Alzheimer’s disease
- Amyloid A-Beta Peptide: In-Cell Studies and Mechanism of Polyphenol-Based Inhibition to Aggregation
- Amyloid precursor protein‐mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer’s disease
- Amyloid β-Peptide (1–42)-Induced oxidative stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression
- Amyloid β-protein assembly as a therapeutic target of Alzheimer’s disease
- Amyloid‐β deposition in Alzheimer transgenic mice is associated with oxidative stress
- An alternative approach to drug discovery for Alzheimer’s disease dementia
- An Evaluation of Cholesterol-lowering Effect of Soy Protein and Isoflavones on Postmenopausal Women and Hypercholesterolemic Humans.
- An Overview of Parkinson’s Disease and Oxidative Stress: Herbal Scenario
- An overview of the possible therapeutic role of SUMOylation in the treatment of Alzheimer’s disease
- An overview on global trends in nanotechnological approaches for Alzheimer therapy
- An overview on potential neuroprotective compounds for management of Alzheimer’s disease
- An overview on therapeutics attenuating amyloid β level in Alzheimer’s disease: Targeting neurotransmission, inflammation, oxidative stress and enhanced …
- An update on plant-originated treatment for Alzheimer’s disease
- An updated review on Anti-Alzheimer’s herbal drugs
- Analgesic and acetylcholinesterase inhibition potential of polyphenols from Scolopia crenata (Flacourtiaceae): An endemic medicinal plant of India
- Analysis of amino acid and phenolic content in honey by UPLC-ESI-MS/MS
- Analysis of technological developments in the treatment of Alzheimer’s disease through patent documents
- Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson’s Disease
- Anesthesia Implications of the Use of Essential Oils in Alzheimer’s Dementia
- Animal models of Parkinson’s disease: a gateway to therapeutics?
- Anthocyanins Potentially Contribute to Defense against Alzheimer’s Disease
- Anthocyanins restore behavioral and biochemical changes caused by streptozotocin-induced sporadic dementia of Alzheimer’s type
- Anti-acetylcholinesterase and antioxidant activities and HPLC-MS analysis of polyphenol from extracts of Nelsonia canescens (Lam.) Spreng.
- Anti-adipogenic Effect of a Dietary flavonoid Fisetin in 3T3-L1 Cells
- Anti-aging and anti-aggregation properties of polyphenolic compounds in C. elegans
- Anti-Alzheimer potential of Green Moong Bean
- Anti-Alzheimer’s studies on β-sitosterol isolated from Polygonum hydropiper L.
- Anti-amnesic Effect of Leea indica Extract in Scopolamine-induced Amnesia of Alzheimer’s Type in Rats
- Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer’s β-amyloid fibrils in vitro
- Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer’s disease
- Anti-amyloidogenic properties of some phenolic compounds
- Anti-Demential Effect of EGB 761 on dementia Induced Wistar Rats
- Anti-Inflammatory Agents in Parkinson’s Disease
- Anti-inflammatory and immune therapy for Alzheimer’s disease: current status and future directions
- Anti-inflammatory and immunomodulatory properties of dietary flavonoids
- Anti-inflammatory Effects of flavonoid Compounds on TNBS-induced Acute Colitis in Rats
- Anti-inflammatory effects of flavonoids in Neurodegenerative disorders
- Anti-inflammatory Effects of O-methylated Flavonoid
- Anti-inflammatory, anti-diabetic, and anti-Alzheimer’s effects of prenylated flavonoids from Okinawa propolis: an investigation by experimental and computational …
- Anti-inflammatory, immunomodulatory, and prebiotic properties of dietary flavonoids
- Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer’s disease
- Anti-Parkinson potential of silymarin: mechanistic insight and therapeutic standing
- Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models?
- Antiaging Interventions: An Insight into Polyphenols and Brain Aging
- Antiapoptotic role of Agaricus blazei extract in rodent model of Parkinson’s disease
- Antidementic activity of Brassica oleracea l. var. Italica (brassicaceae) flower on memory deficit in young male rats
- Antidepressant flavonoids and their relationship with oxidative stress
- Antihepatotoxic, nephroprotective, and antioxidant activities of phenolic compounds from Satureja macrostema leaves against carbon tetrachloride-induced hepatic …
- Antioxidant activity and total phenolic content of ethanolic extract of Caesalpinia bonducella seeds
- Antioxidant activity of selected phenols estimated by ABTS and FRAP methods.
- Antioxidant Activity of Wine Polyphenols for Alzheimer Prevention
- Antioxidant and anti‐inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental …
- Antioxidant and Anticholinesterase Activities of Macrosphyra Longistyla (DC) Hiern Relevant in the Management of Alzheimer’s Disease
- Antioxidant and Choline Esterase Inhibitory Activity of Phenolic Rich Extracts from Bombax ceiba L. Flowers.
- Antioxidant and neuroprotective Effects of Synthetic Curcumin Analogues and Natural Phenolics
- Antioxidant and neuroprotective properties of blueberry polyphenols: a critical review
- Antioxidant and pro-oxidant effects of polyphenolic compounds and structure-activity relationship evidence
- Antioxidant Capacity and Behavioral Relevance of a Polyphenolic Extract of Chrysanthellum americanum in a Rat Model of Irritable Bowel Syndrome
- Antioxidant Capacity is Decreased in Alzheimer’s Disease and Mild Cognitive Impairment Patients
- ANTIOXIDANT EFFECT OF flavonoids IN Neurodegenerative DISEASES.
- Antioxidant effect of flavonoids present in Euterpe oleracea Martius and Neurodegenerative diseases: A literature review
- Antioxidant neuroprotection in Alzheimer’s disease as preventive and therapeutic approach
- Antioxidant Nutraceuticals and Parkinson’s Disease
- Antioxidant phenolic constituents from Parthenocissus tricuspidata
- Antioxidant plant polyphenols and cognitive disorders
- ANTIOXIDANT PROPERTIES OF A Ginkgo biloba LEAF EXTRACT (EGb 761) IN ANIMAL MODELS OF Alzheimer’s AND Parkinson’s DISEASES.
- Antioxidant properties of Crocus sativus L. and its constituents and relevance to Neurodegenerative diseases; focus on Alzheimer’s and Parkinson’s disease
- Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer’s disease
- Antioxidant therapy in Alzheimer’s disease: theory and practice
- Antioxidants and Alzheimer’s disease: from bench to bedside (and back again)
- Antioxidants and dementia risk: consideration through a cerebrovascular perspective
- Antioxidants as a potential therapy against age-related Neurodegenerative diseases: amyloid beta toxicity and Alzheimer’s disease
- Antioxidants in the Prevention and Treatment of Alzheimer’s Disease
- Antioxidants, diet, polyphenols and dementia
- Apolipoprotein ε-4 as a genetic determinant of Alzheimer’s disease heterogeneity
- Apples and their products effect on neurodegeneration and Alzheimer’s disease
- Application of yeast to study the tau and amyloid-β abnormalities of Alzheimer’s disease
- Applying Epigenetics to Alzheimer’s Disease via the Latent Early–life Associated Regulation (LEARn) Model
- Applying transcriptomic and proteomic knowledge to Parkinson’s disease drug discovery
- Approaches Based on Cholinergic Hypothesis and Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
- Are polyphenols strong dietary agents against neurotoxicity and neurodegeneration?
- Arecanut (Areca catechu L) decreases Alzheimer’s disease symptoms: Compilation of research works
- Artemisia amygdalina Upregulates Nrf2 and Protects Neurons Against oxidative stress in Alzheimer Disease
- Asparagus cochinchinensis stimulates release of nerve growth factor and abrogates oxidative stress in the Tg2576 model for Alzheimer’s disease
- Assessment of anticholinesterase activities and antioxidant potentials of Anisomeles indica relevant to the treatment of Alzheimer’s disease
- Assessment of the effect of selected African plants on an in vitro model of Parkinson’s disease
- association of tea consumption with risk of Alzheimer’s disease and anti-beta-amyloid effects of tea
- ATR-IR study of the mechanism of aluminum chloride induced Alzheimer’s disease; curative and protective effect of Lipidium sativum water extract on …
- Attention-deficit/
hyperactivity disorder–unifying mechanism involving antioxidant therapy: Phenolics, reactive oxygen species, and oxidative stress - Attenuation of iNOS and COX2 by blueberry polyphenols is mediated through the suppression of NF-κB activation
- Auraptene Mitigates Parkinson’s Disease-Like Behavior by Protecting Inhibition of Mitochondrial Respiration and Scavenging Reactive Oxygen Species
- Autophagy in Alzheimer’s disease and promising modulatory effects of herbal medicine
- Autophagy, polyphenols and healthy ageing
- Aβ propagation and strains: implications for the phenotypic diversity in Alzheimer’s disease
- BACE inhibitors as potential therapeutics for Alzheimer’s disease
- BACE1 (β-secretase) inhibitors for the treatment of Alzheimer’s disease
- Baicalein reduces β‐amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model
- Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease
- Behavioral and neurochemical alterations induced by vanillin in a mouse model of Alzheimer’s disease
- Beneficial effect of flavone derivatives on Aβ-induced memory deficit is mediated by peroxisome proliferator-activated receptor γ coactivator 1α: a comparative study
- Beneficial effect of the flavonoid luteolin on neuroinflammation
- Beneficial effects of flavonoids against Parkinson’s disease
- Beneficial Effects of flavonoids on Neurological Disorders
- Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson’s disease: the role of glia and NRf2 regulation
- Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration
- Beneficial effects of phenolic compounds from fruit and vegetables in Neurodegenerative diseases
- Beneficial effects of polyphenols on chronic diseases and ageing
- Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation
- Benefits from dietary polyphenols for brain aging and Alzheimer’s disease
- Berry phenolics and their antioxidant activity
- Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer’s disease
- Beyond antioxidants: the cellular and molecular interactions of flavonoids and how these underpin their actions on the brain
- Biflavonoids as potential small molecule therapeutics for Alzheimer’s disease
- Bioactive composition and promising health benefits of natural food flavors and colorants: potential beyond their basic functions
- Bioactive flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers-Implications for Parkinson’s Disease
- Bioactivity of olive oil phenols in neuroprotection
- Bioanalytical Approach to the Interaction of Novel sym-Triazine Derivatives with Alzheimer’s Disease Biomarkers
- Bioanalytical Approaches to Investigate Antioxidant Molecules and Nucleic Acid-Protein Interactions in Alzheimer’s Disease
- Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts
- Bioavailability and pharmaco-therapeutic potential of luteolin in overcoming Alzheimer’s disease
- Bioavailability of dietary polyphenols: Factors contributing to their clinical application in CNS diseases
- Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update
- Biochanin-A ameliorates behavioural and neurochemical derangements in cognitive-deficit mice for the betterment of Alzheimer’s disease
- Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis
- Biological reactivity of polyphenolic− glutathione conjugates
- Biopharmaceutical Monotargeting versus ‘Universal Targeting’of Late-Onset Alzheimer’s Disease Using Mixtures of Pleiotropic Natural Compounds
- Biophenols pharmacology against the amyloidogenic activity in Alzheimer’s disease
- Biophenols: Enzymes (β-secretase, Cholinesterases, histone deacetylase and tyrosinase) inhibitors from olive (Olea europaea L.)
- Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from …
- Bioprocessing Strategies to Enhance L-DOPA and Phenolic Bioactives in the Fava Bean (Vicia Faba)
- Biosynthesized metal nanoparticles as potential Alzheimer’s disease therapeutics
- Black tea theaflavins inhibit formation of toxic amyloid-β and α-synuclein fibrils
- Blanching alters the phenolic constituents and in vitro antioxidant and anticholinesterases properties of fireweed (Crassocephalum crepidioides)
- Blueberry polyhphenols and neuroprotection
- Blueberry polyphenols and neuroprotection
- Botanical phenolics and brain health
- Botanics: a potential source of new therapies for Alzheimer’s disease
- Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer’s disease
- Brain food for Alzheimer-free ageing: focus on herbal medicines
- Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease
- Brain iron accumulation in Parkinson’s disease: An investigation of genes related to iron metabolism and homeostasis and dietary behavior data in a case …
- Brain iron metabolism dysfunction in Parkinson’s disease
- Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson’s disease
- C0550 Neuroinflammation in Alzheimer’s Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals
- Caffeic acid attenuates oxidative stress, learning and memory deficit in intra-cerebroventricular streptozotocin induced experimental dementia in rats
- Can co-activation of Nrf2 and neurotrophic signaling pathway slow Alzheimer’s disease?
- Can consuming flavonoids restore old microglia to their youthful state?
- Can we prevent Parkinson’s disease
- Cannabis Flavonoids—Antioxidant & Anti-Inflammatory Benefits
- Carbohydrates and Glycomimetics in Alzheimer’s Disease Therapeutics and Diagnosis
- Carbon nanomaterials and amyloid beta interactions: Possible potentials in the detection and treatment of Alzheimer’s disease
- Catechin polyphenols: neurodegeneration and neuroprotection in Neurodegenerative diseases
- Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG)
- Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐
gallate: implications for Neurodegenerative diseases - Cellular and molecular aspects of Parkinson treatment: future therapeutic perspectives
- Cellular and molecular mechanisms of antioxidants in Parkinson’s disease
- Cellular phenotypes as inflammatory mediators in Parkinson’s disease: interventional targets and role of natural products
- Cerebral area differential redox response of neonatal rats to selenite-induced oxidative stress and to concurrent administration of highbush blueberry leaf polyphenols
- Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer’s …
- Challenges for research on polyphenols from foods in Alzheimer’s disease: bioavailability, metabolism, and cellular and molecular mechanisms
- Champagne wine polyphenols protect primary cortical neurons against peroxynitrite-induced injury
- Changing paradigm from one target one ligand towards multi-target directed ligand design for key drug targets of Alzheimer disease: an important role of in silico …
- Characterization of Copper Interactions with Alzheimer Amyloid β Peptides: Identification of an Attomolar‐Affinity Copper Binding Site on Amyloid β1‐42
- Characterization of Copper Interactions with Alzheimer Amyloid β Peptides: Identification of an Attomolar‐Affinity Copper Binding Site on Amyloid β1‐42
- Characterization of neurotoxic effects of NMDA and the novel neuroprotection by phytopolyphenols in mice.
- Characterization of phenolic compounds using UPLC–HRMS and HPLC–DAD and anti-cholinesterase and anti-oxidant activities of Trifolium repens L. leaves
- CHARACTERIZATION OF THE neuroprotective ACTIVITY OF THE polyphenol (-)-EPIGALLOCATECHIN-3-GALLATE IN THE BRAIN
- Charnoly body as a novel biomarker of nutritional stress in Alzheimer’s Disease
- Chemical fingerprint of Bacopa monnieri L. and Rosmarinus officinalis L. and their neuroprotective activity against Alzheimer’s disease in rat model’s putative …
- Chemical structures, bioactivities and molecular mechanisms of citrus polymethoxyflavones
- Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson’s disease
- Chocolate and the brain: neurobiological impact of cocoa flavanols on cognition and behavior
- Chocolate/Cocoa Polyphenols and Oxidative Stress
- Cholinesterase inhibitors as Alzheimer’s therapeutics
- Chroman-like cyclic prenylflavonoids promote neuronal differentiation and neurite outgrowth and are neuroprotective
- Chronic dietary supplementation of 4% figs on the modification of oxidative stress in Alzheimer’s disease transgenic mouse model
- Chronic Hypoxia Alters mRNA Expression of the Genes Related to Alzheimer’s Disease in Primary Neuronal Cells
- Chronic neuroinflammation in Alzheimer’s disease: new perspectives on animal models and promising candidate drugs
- Chronic treatment with resveratrol, a natural polyphenol found in grapes, alleviates oxidative stress and apoptotic cell death in ovariectomized female rats subjected to …
- Cinnamon, a promising prospect towards Alzheimer’s disease
- Citrus Fruit Polyphenols and Flavonoids: Applications to Psychiatric Disorders
- Clinical benefit and preservation of flavonols in dark chocolate manufacturing
- Clinical Development of a Novel Parkinsonian Drug in USA
- Cocoa and dark chocolate polyphenols: from biology to clinical applications
- Cocoa flavanols, exercise and the brain
- Cocoa Powder Triggers neuroprotective and Preventive Effects in a Human Alzheimer 0 s Disease Model by Modulating BDNF Signaling Pathway
- Cocoa powder triggers neuroprotective and preventive effects in a human Alzheimer’s disease model by modulating BDNF signaling pathway
- Coffee phenolic phytochemicals and kaempferol protect against oxidative damage of neuronal cells and memory impairments
- Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review
- Cognitive Function and Consumption of Fruit and Vegetable Polyphenols in a Young Population: Is There a Relationship?
- Cognitive stimulation with leisure activities for prevention of cognitive decline and dementia: The aktiva study
- Cognitive-enhancing effect of quercetin in a rat model of Parkinson’s disease induced by 6-hydroxydopamine
- Combating oxidative stress disorders with citrus flavonoid: Naringenin
- Combination of EPA with carotenoids and polyphenol synergistically attenuated the transformation of microglia to M1 phenotype via inhibition of NF-κB
- Commentary: The flavonoid Baicalein Rescues Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer’s Disease
- Comparative analysis of total phenolic and total flavonoid contents, rutin, tannins and antioxidant capacity in Apiaceae and Lamiaceae families
- Comparative antioxidant activity of twenty traditional Indian medicinal plants and its correlation with total flavonoid and phenolic content
- Comparative evaluation of Helichrysi flos herbal extracts as dietary sources of plant polyphenols, and macro-and microelements
- Comparative evaluation of the antioxidant and anti-Alzheimer’s disease potential of coumestrol and puerarol isolated from pueraria lobata using molecular modeling …
- Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer’s disease and some pro-oxidant induced oxidative …
- Comparison of protective effects of four polyphenols on neuropathology and behavior of APP/PS1-21 transgenic mice, a model of Alzheimer’s disease
- Comparison of Three Amyloid Assembly Inhibitors: The Sugar scyllo-Inositol, the polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01
- Complementary Therapies for Parkinson’s Disease: What’s Promoted, Rationale, Potential Risks and Benefits
- Compositional Changes in Anthocyanins, Flavonols, and Ellagitannins in Processed Blackberries
- Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
- Computational approaches to the investigation of proteins involved in Parkinson’s Disease
- Computational modeling of multi-target-directed inhibitors against Alzheimer’s disease
- Computer-aided structure-based design of multitarget leads for Alzheimer’s disease
- Conjugates of catecholamines with cysteine and GSH in Parkinson’s disease: possible mechanisms of formation involving reactive oxygen species
- Conservative iron chelation for Neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis
- Considerations for the use of polyphenols as therapies in Neurodegenerative diseases
- Consumption of anthocyanin-rich cherry juice for 12 weeks improves memory and cognition in older adults with mild-to-moderate dementia
- Consumption of fig fruits grown in Oman can improve memory, anxiety, and learning skills in a transgenic mice model of Alzheimer’s disease
- Consumption of polyphenol plants may slow aging and associated diseases
- Contribution of Intracellular Non-Haem Iron, NF-kB Activation and Inflammatory Responses to Neurodegeneration in Parkinson’s Disease: Prospects for …
- Contribution of Intracellular Non-Haem Iron, NF-kB Activation and Inflammatory Responses to Neurodegeneration in Parkinson’s Disease: Prospects for …
- Copper-Catalyzed Oxidative Esterification of 2-Carbonyl Substituted Phenols with Alcohols
- Correlation between the polyphenol content and antioxidant effect of Cynara scolymus L. mother tincture
- Critical Evaluation of Current Alzheimer′ s Drug Discovery (2018-19) & Futuristic Alzheimer drug model approach
- Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson’s disease
- Curcumin and Apigenin–novel and promising therapeutics against chronic neuroinflammation in Alzheimer’s disease
- Curcumin and Its Nanoformulations as Therapeutic for Alzheimer’s Disease
- Curcumin exposure induces expression of the Parkinson’s disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells
- Curcumin has potent anti‐amyloidogenic effects for Alzheimer’s β‐amyloid fibrils in vitro
- Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models
- Curcumin prevents and ameliorates biochemical and behavioral toxicities of MPTP in C57Bl/6J mice: its potential use in preventing and treating parkinsonism
- Curcumin-glucoside, a novel synthetic derivative of curcumin, inhibits α-synuclein oligomer formation: relevance to Parkinson’s disease
- Current Alzheimer’s management with berries fruits therapy
- CURRENT Alzheimer’s MANAGEMENT WITH DIETARY SEEDS THERAPY
- Current and emerging pharmacological targets for the treatment of Alzheimer’s disease
- Current and emerging therapeutic targets of Alzheimer’s disease for the design of multi-target directed ligands
- Current and investigational drugs for treatment of Alzheimer’s disease
- Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer’s disease
- Current evidence on the effect of dietary polyphenols intake on chronic diseases
- Current opinions and perspectives on the role of immune system in the pathogenesis of Parkinson’s disease
- Current perspectives and mechanisms of relationship between intestinal microbiota dysfunction and dementia: a review
- Current pharmacotherapy and putative disease-modifying therapy for Alzheimer’s disease
- Current status of metals as therapeutic targets in Alzheimer’s disease
- Cytological profiling of natural product scaffolds libraries for Parkinson’s disease
- Cytoprotection by Achyrocline satureioides (Lam) DC and some of its main flavonoids against oxidative stress
- Cytoprotective effects of phenolic antioxidants and essential fatty acids in human blood monocyte and neuroblastoma cell lines: Surrogates for neurological damage in …
- De B. Acetylcholinesterase inhibitory properties of black tea and its polyphenolic components
- Defective insulin signalling, mediated by inflammation, connects obesity to Alzheimer disease; relevant pharmacological therapies and preventive dietary …
- dementia IN SURINAME
- Dementia, preclinical studies in neurodegeneration and its potential for translational medicine in South America
- Design and characterization of enzymatic deglycosylation systems to produce drugs against Alzheimer’s disease
- Design and development of novel irreversible GSK-3β inhibitors to address Alzheimer’s disease
- Design and Molecular dynamic investigations of 7, 8-Dihydroxyflavone Derivatives as potential neuroprotective Agents Against Alpha-synuclein
- Design and Molecular dynamic Investigations of 7, 8-Dihydroxyflavone Derivatives as Potential neuroprotective Agents Against Alpha-synuclein
- Design and systhesis of nanoparticles for therapy and imaging of Alzheimer’s disease
- Design of Multi-target Directed Ligands as a Modern Approach for the Development of Innovative Drug Candidates for Alzheimer’s Disease
- Design, Synthesis and Biological Assessment of Ferulic Acid Derivatives as Inhibitors of β-Amyloid Oligomerization in Alzheimer’s Disease
- Design, synthesis and biological evaluation of 3-piperazinecarboxylate sarsasapogenin derivatives as potential multifunctional anti-Alzheimer agents
- Design, synthesis and biological evaluation of scutellarein derivatives as potential anti-Alzheimer’s disease candidates based on metabolic mechanism
- Design, synthesis and evaluation of 4′-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer’s disease treatment
- Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer’s disease
- Designing multi-targeted therapeutics for the treatment of Alzheimer’s disease
- Destabilization of Alzheimer’s Aβ42 protofibrils with a novel drug candidate wgx-50 by molecular dynamics simulations
- Determination of Flavonoids
- Determination of total flavonoid content of different parts of Garcinia cowa
- Development and application of nano-flavor-drug carriers in Neurodegenerative diseases
- Development and validation of analytical methods for the identification and quantification of phenolic compounds from Euterpe oleracea fruits
- Development of a grape seed polyphenolic extract with anti‐oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies
- Development of Electrochemical Sensors for the Analysis of Therapeutic Compounds and Proteases related to Alzheimer’s disease
- Development of multifunctional molecules as potential therapeutic candidates for Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis in the …
- Development of tau aggregation inhibitors for Alzheimer’s disease
- Development of technologies for the production of polyphenolic nutraceuticals from muscadine grapes and rabbiteye blueberries
- Developments with multi-target drugs for Alzheimer’s disease: an overview of the current discovery approaches
- Diabetes and Alzheimer’s disease: can tea phytochemicals play a role in prevention?
- Diet and brain health: which role for polyphenols?
- Diet And Lifestyle Guidelines And Desirable Levels Of Risk Factors And Protective Factors For Prevention Of Dementia-A Scientific Statement From Joint …
- Diet and medical foods in Parkinson’s disease
- Diet and Nutrition in Alzheimer’s Disease and Healthy Aging
- Diet and Nutrition in Alzheimer’s Disease and Healthy Aging
- Diet and nutrition in dementia and cognitive decline
- Diet and the Risk of Parkinson’s Disease—Research Suggests Dietary Interventions May Prevent It and Lessen Symptom Severity By Densie Webb, PhD, RD
- Diet, nutrients and metabolism: cogs in the wheel driving Alzheimer’s disease pathology?
- Dietary coconut and amyloid beta metabolism in the pathogenesis of Alzheimer’s disease
- Dietary Directions Against dementia Disorders
- Dietary factors in the etiology of Parkinson’s disease
- Dietary fatty acids and predementia syndromes
- Dietary fatty acids intake: possible role in cognitive decline and dementia
- Dietary fatty acids, cognitive decline, and dementia
- Dietary flavonoid intake in older adults: how many days of dietary assessment are required and what is the impact of seasonality?
- Dietary flavonoid intake to reduce the risk of chronic diseases
- Dietary flavonoids as potential neuroprotectants
- Dietary flavonoids Interaction with CREB-BDNF Pathway: An Unconventional Approach for Comprehensive Management of Epilepsy
- Dietary intake of natural antioxidants: vitamins and polyphenols
- Dietary lipids and their oxidized products in Alzheimer’s disease
- Dietary modifications in Parkinson’s disease: A neuroprotective intervention?
- Dietary modulation of oxidative stress in Alzheimer’s disease
- Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity
- Dietary phenolics in apples and cider and their bioavailability in healthy humans and subjects with an ileaostomy
- Dietary Plant Lectins May be an ‘Unknown Etiology’in Parkinson’s Disease and Dietary Bioactive Compounds Affect Lifespan and Fat Storage Aspects of …
- Dietary polyphenols and mitochondrial function: role in health and disease
- Dietary polyphenols and neurogenesis: Molecular interactions and implication for brain ageing and cognition
- Dietary polyphenols and the prevention of diseases
- Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects
- Dietary Polyphenols as Modulators of Brain Functions: Biological Actions and Molecular Mechanisms…
- Dietary polyphenols as potential remedy for dementia
- Dietary Polyphenols—Important Non-Nutrients in the Prevention of Chronic Noncommunicable Diseases. A Systematic Review
- Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer’s Disease
- Dietary polyphenols: A novel strategy to modulate microbiota-gut-brain axis
- Dietary Strategies and Supplements for the Prevention of Cognitive Decline and Alzheimer’s Disease
- Dietary supplementation of walnut partially reverses 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine induced neurodegeneration in a mouse model of Parkinson’s …
- Dietary supplementation with fruit polyphenolics ameliorates age-related deficits in behavior and neuronal markers of inflammation and oxidative stress
- Dietary Supplements as Cognitive Enhancers: The Role of Flavonoid-Rich Foods and their Relevance in Age-Related Neurodegeneration
- Dietary total prenylflavonoids from the fruits of Psoralea corylifolia L. prevents age-related cognitive deficits and down-regulates Alzheimer’s markers in SAMP8 mice
- Differential oxidative stress in oligodendrocytes and neurons after excitotoxic insults and protection by natural polyphenols
- Differential Protection among Fractionated Blueberry Polyphenolic Families against DA-, Aβ42- and LPS-Induced Decrements in Ca2+ Buffering in Primary …
- Direct Evaluation of Alzheimer’s Disease-Specific oxidative stress with Multiphoton Microscopy
- Discovery development of drugs for alzheimers disease neuroinflammation and elucidating their molecular mechanism of action
- Discovery of Gut Bacteria Specific to Alzheimer’s Associated Diseases is a Clue to Understanding Disease Etiology: Meta-Analysis of Population-Based Data on …
- Discovery of Natural Products from Curcuma longa that Protect Cells from Beta-Amyloid Insult: A Drug Discovery Effort against Alzheimer’s Disease
- Disease contraindication drug use behavior in patients with Parkinson’s disease
- Disruption of Calcium Homeostasis in Alzheimer’s Disease: Role of Channel Formation by β Amyloid Protein
- Dissecting molecular mechanisms in the living brain of dementia patients
- Divergent synthesis of biflavonoids yields novel inhibitors of the aggregation of amyloid β (1–42)
- Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations
- Docking of GSK-3β with novel inhibitors, a target protein involved in Alzheimer’s disease
- Docking study and structure-activity relationships of human glutaminyl cyclase inhibitors for the drug discovery of Alzheimer’s disease
- Does Parkinson’s disease and type-2 diabetes mellitus present common pathophysiological mechanisms and treatments?
- Dopamine-Mediated oxidative stress Associated with Neurodegeneration in Parkinson Disease
- Dopaminergic Neuroprotection with Atremorine in Parkinson´ s Disease
- Down regulation effect of Rosmarinus officinalis polyphenols on cellular stress proteins in rat pheochromocytoma PC12 cells
- Down regulation effect of Rosmarinus officinalis polyphenols on cellular stress proteins in rat pheochromocytoma PC12 cells
- Dracocephalum moldavica L. and Melissa officinalis L.: Chemistry and bioactivities relevant in Alzheimer’s disease therapy
- Drug delivery systems for resveratrol, a non-flavonoid polyphenol: Emerging evidence in last decades
- Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer’s disease
- Dual inhibitors of monoamine oxidase and cholinesterase for the treatment of Alzheimer disease
- Dual/multitargeted xanthone derivatives for Alzheimer’s disease: where do we stand?
- DYRK1A inhibition as potential treatment for Alzheimer’s disease
- Dysregulation of stress systems and nitric oxide signaling underlies neuronal dysfunction in Alzheimer’s disease
- Early vitamin E supplementation in young but not aged mice reduces Aβ levels and amyloid deposition in a transgenic model of Alzheimer’s disease
- Eat to Beat Alzheimer’s
- EFEITO PROTETOR DO RESVERATROL NA DOENÇA DE ALZHEIMER
- Effect of Antioxidant Flavanone, Naringenin, from Citrus junos on Neuroprotection
- Effect of Black Raisins (Vitis vinifera) on Aluminum Chloride Induced Alzheimer’s Disease in Male Albino Rat.
- Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer’s disease in rats
- Effect of Chinese herbal medicine on Alzheimer’s disease
- Effect of dietary supplementation of dates in Alzheimer’s disease APPsw/2576 transgenic mice on oxidative stress and antioxidant status
- Effect of extraction procedures, genotypes and screening methods to measure the antioxidant potential and phenolic content of orange-fleshed sweetpotatoes …
- Effect of Imperatorin in Neuropathology of Parkinson’s Disease: An In Silico Study
- Effect of oil palm phenolics on beta amyloid deposition in cholesterol induced rat model of Alzheimer’s disease: Histological evidence
- Effect of phenolic-rich plant materials on protein and lipid oxidation reactions
- Effect of plant extracts on Alzheimer’s disease: An insight into therapeutic avenues
- Effect of polyphenols on oxidative stress and mitochondrial dysfunction in neuronal death and brain edema in cerebral ischemia
- Effect of polyphenols on protein misfolding
- Effects and mechanisms of actions of phytochemicals on Alzheimer’s disease neuropathology
- Effects and Possible Mechanisms of Some Phytochemicals on Drosophila Models of Alzheimer’s Disease
- Effects of berry polyphenols on cognitive function in humans
- Effects of Berry, Pomegranate, Grape and their Biophenols on Cognitive Function: A General Re-view
- Effects of biflavonoids from Garcinia madruno on a triple transgenic mouse model of Alzheimer’s disease
- Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia
- Effects of Dietary Components on Microglia Inactivation in Alzheimer’s Disease
- Effects of dietary docosahexaenoic acid supplementation on pathology and cognition in a mouse model of Alzheimer’s disease
- Effects of essential oils and aromatherapy on cognitive function in dementia: laboratory studies and application in aged care facility residents
- Effects of fisetin on hyperhomocysteinemia-induced experimental endothelial dysfunction and vascular dementia
- Effects of flavonoids on MMP-13 Expression of IL-1β-treated Articular Chondrocytes and Their Cellular Mechanisms: Inhibition of c-Fos/AP-1 and JAK/STAT …
- Effects of green tea polyphenol on cognitive and acetylcholinesterase activities
- Effects of Horticultural Activities and Flower Tea Drinking Based on Reminiscent Storytelling on Demented Elders’ Cognitive and Emotional Functions
- Effects of huanglian-jie-du-tang and its modified formula on the modulation of amyloid-β precursor protein processing in Alzheimer’s disease models
- Effects of Isoflavone Extract from Fermented Soybean, Chungkukjang, on Cell Cycle Arrest and Apoptosis of MCF-7 Cells
- Effects of long-term administration of a cocoa polyphenolic extract (Acticoa powder) on cognitive performances in aged rats
- Effects of medicinal plants on Alzheimer’s disease and memory deficits
- Effects of peptides on the structure of lipid bilayers: Implication for its therapeutic effect in Alzheimer’s disease
- Effects of polyphenols on brain ageing and Alzheimer’s disease: focus on mitochondria
- Effects of resveratrol and other polyphenols on Sirt1: relevance to brain function during aging
- Effects of resveratrol and other polyphenols on the most common brain age-related diseases
- Effects of stilbenoid polyphenols (pterostilbene and gnetol) on cardiomyocyte hypertrophy in vitro and in vivo in spontaneously hypertensive heart failure rats
- Effects of tea catechins on Alzheimer’s disease: Recent updates and perspectives
- Effects of the flavonoids, silibinin and catechin, on the motility of extended cooled caprine sperm
- Effects of various flavonoids on the-synuclein fibrillation process
- Effects on Cognition of Berry, Pomegranate, Grape and Biophenols: A General Review
- EFFICACY STUDY OF BRAHMYADI YOGA IN THE MANAGEMENT OF Alzheimer’s DISEASE (SMRITI BHRAMSHA)
- EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer’s disease
- Electroanalysis of α-Synuclein Aggregation Related to Parkinson’s Disease
- Electrochemical biosensors for the detection and study of α-synuclein related to Parkinson’s disease–A review
- Emerging role of polyphenolic compounds in the treatment of Neurodegenerative diseases: a review of their intracellular targets
- Emerging Signal Regulating Potential of Genistein against Alzheimer Disease: A Promising Molecule of Interest
- Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer’s disease
- Enhancing human cognition with cocoa flavonoids
- Enrichment of phenolic antioxidants from cranberry (Vaccinium macrocarpon) to improve biological functionality
- Epigallocatechin gallate (EGCG) inhibits alpha-synuclein aggregation: a potential agent for Parkinson’s disease
- Epigallocatechin-3-gallate and related phenol compounds redirect the amyloidogenic aggregation pathway of ataxin-3 towards non-toxic aggregates and prevent …
- Epigallocatechin-3-gallate, a promising molecule for Parkinson’s disease?
- Epigenetic drug discovery for Alzheimer’s disease
- Epigenetic effects of natural polyphenols: A focus on SIRT1‐mediated mechanisms
- ESPEN guidelines on nutrition in dementia
- Establishing a Connection between Alzheimer’s Disease and Cellular Energy Transduction
- Establishment of CD method for studies of amyloid-oligomerization process during Alzheimer disease
- Estimation of antioxidative properties of the natural polyphenols in the oxidation process of model liposome membranes
- Estimation of dietary flavonoid intake and major food sources of Korean adults
- Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: key role of neuron-glia crosstalk
- Ethanol extract of Epipremnum aureum leaves attenuate intranigral-rotenone induced Parkinson’s disease in rats
- Ethnobotanical treatment strategies against Alzheimer’s disease
- Ethnomedicinal Survey of Plants Used as Remedy for Alzheimer’s Disease in Ebonyi State, Nigeria
- Ethnopharmacological approaches for dementia therapy and significance of natural products and herbal drugs
- Eupatilin: a natural pharmacologically active flavone compound with its wide range applications
- Evaluating the neuroprotective effects of fermented rooibos herbal tea in Wistar rats exposed to bisphenol-A during gestation and lactation
- Evaluation of anti-oxidant activities and total phenolic content of Chromolaena odorata
- Evaluation of antioxidant activities and total phenolic content of methanolic extract of Rhodiola heterodanta roots
- evaluation of antiparkinson activity of hesperetin pyridoxine against olanzepine and manganese induced parkinsonism
- Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer’s disease
- Evaluation of Memory Enhancing Activity of Methanolic Extract of Oxalis corniculata Linn on dementia in Experimental Animals
- Evaluation of plant phenolic metabolites as a source of Alzheimer’s drug leads
- Evaluation of the neuroprotective and antidiabetic potential of phenol-rich extracts from virgin olive oils by in vitro assays
- Evaluation to the antioxidant activity of total flavonoids extract from persimmon (Diospyros kaki L.) leaves
- Evidence of neuroprotective effects of saffron and crocin in a Drosophila model of parkinsonism
- Evidence of oxidative stress in Alzheimer’s disease brain and antioxidant therapy: lights and shadows
- Evolutionary medicine’perspectives on Alzheimer’s Disease: Review and new directions
- Exploration of Mitochondrial Dysfunction, Depolarization and Polyphenols by Creative Synthesis for Product Development
- Exploring the benefits of cellular models to uncover bioactive polyphenols for neurodegeneration
- Exploring the bioavailability of (poly) phenols from berries and their potential activities in humans
- Exploring the efficacy of natural products in alleviating Alzheimer’s disease
- Exploring the mechanism of flavonoids through systematic bioinformatics analysis
- Exploring the potential of marine microbes in clinical management of Alzheimer’s disease: A road map for bioprospecting and identifying promising isolates
- Extra-virgin olive oil for potential prevention of Alzheimer disease
- Extra-virgin olive oil for potential prevention of Alzheimer disease
- Factors affecting the levels of tea polyphenols and caffeine in tea leaves
- Fate of microbial metabolites of dietary polyphenols in rats: is the brain their target destination?
- Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer’s disease
- Ferulic Acid and Alzheimer’s Disease: Promises and Pitfalls
- Fight Alzheimer’s with Vitamins and Antioxidants
- Fight Parkinson’s and Huntington’s with Vitamins and Antioxidants
- First synthesis of the antiangiogenic homoisoflavanone, cremastranone
- Flavan-3-ol compounds from wine wastes with in vitro and in vivo antioxidant activity
- Flavanols, mild cognitive impairment, and Alzheimer’s dementia
- Flavanonol glucosides from the aerial parts of Agrimonia pilosa Ledeb. and their acetylcholinesterase inhibitory effects
- Flavins and flavoproteins: applications in medicine
- Flavone: An Important Scaffold for Medicinal Chemistry
- Flavones from root of Scutellaria baicalensis Georgi: drugs of the future in neurodegeneration?
- Flavones from the root of Scutellaria baicalensis Georgi—drug of the future in neurodegeneration and neuroprotection
- Flavones: An important scaffold for medicinal chemistry
- flavonoid baicalein attenuates activation-induced cell death of brain microglia
- flavonoid bioactivity: transport across blood-brain-barrier and neuroprotective effects. In vivo studies
- flavonoid enhances the glyoxalase pathway in cerebellar neurons to retain cellular functions
- flavonoid hesperidin induces synapse formation and improves memory performance through the astrocytic TGF-β1
- flavonoid in enhancing memory function
- flavonoid inhibitors of alpha-synuclein fibrillation: A therapeutic strategy for Parkinson’s disease, and, The effect of membranes on SMA fibrillation
- flavonoid Intake and Dementia
- flavonoid intake and disability-adjusted life years due to Alzheimer’s and related dementias: a population-based study involving twenty-three developed countries
- flavonoid modulation of GABAA receptors
- flavonoid transport across blood-brain barrier: Implication for their direct neuroprotective actions
- flavonoid transport across RBE4 cells: a blood-brain barrier model
- flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia
- Flavonoid-based therapies in the early management of Neurodegenerative diseases
- Flavonoid-rich foods (FRF): A promising nutraceutical approach against lifespan-shortening diseases
- Flavonoidal Compound Derived from Chrysanthemum indicum L. Suppresses MUC5AC Mucin Gene Expression, Production and Secretion from Cultured …
- Flavonoids
- flavonoids and Aging
- flavonoids and anthranquinones as xanthine oxidase and monoamine oxidase inhibitors: a new approach towards inflammation and oxidative stress
- flavonoids and brain health: multiple effects underpinned by common mechanisms
- flavonoids and cognition: potential therapeutic role in Alzheimer’s disease
- flavonoids and cognition: the molecular mechanisms underlying their behavioural effects
- flavonoids and cognitive function: a review of human randomized controlled trial studies and recommendations for future studies
- flavonoids and dementia: an update
- flavonoids and Diarylheptanoids: neuroprotective Activities of Phytochemicals
- flavonoids and neuroprotection: biochemical and population-based analyses of potential neuroprotective factors related to dementia.
- flavonoids and Phenolic Acids as Potential Natural Antioxidants
- flavonoids and the aging brain
- flavonoids and the brain: Evidences and putative mechanisms for a protective capacity
- flavonoids and their relation to human health
- flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects
- flavonoids as detoxifying and pro-survival agents: What’s new?
- flavonoids as modulators of memory and learning: molecular interactions resulting in behavioural effects
- flavonoids as neuroprotective and therapeutic agents against aging related neurological disorders
- flavonoids as novel neuroprotective nutraceuticals
- flavonoids as prospective neuroprotectants and their therapeutic propensity in aging associated neurological disorders
- flavonoids as regulators of amyloid precursor protein processing
- flavonoids as therapeutic agents in Alzheimer’s and Parkinson’s diseases: a systematic review of preclinical evidences
- flavonoids in Foods and Their Role in Healthy Nutrition
- flavonoids in human health: from structure to biological activity
- flavonoids in neurodegeneration: Limitations and strategies to cross CNS barriers
- flavonoids in the treatment of Alzheimer’s and other Neurodegenerative diseases
- flavonoids in Transgenic Alzheimer’s Disease Mouse Models
- flavonoids in Transgenic Alzheimer’s Disease Mouse Models
- flavonoids inhibit heparin-induced aggregation of the third repeat (r3) of microtubule-binding domain of Alzheimer’s tau protein
- flavonoids possess neuroprotective effects on cultured pheochromocytoma PC12 cells: a comparison of different flavonoids in activating estrogenic effect and in …
- flavonoids with Novel Nicotinic Activity as Potential Pharmacotherapies to Treat Ethanol-Induced Neurotoxicity
- Flavonoids-food sources and health benefits
- Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease
- Flavonoids: an overview
- Flavonoids: Broad Spectrum Agents on Chronic Inflammation
- Flavonoids: important biocompounds in food
- Flavonoids: its working mechanism and various protective roles
- Flavonoids: modulators of brain function?
- Flavonol Glycosides and Phenolic Compounds from Euphorbia maculata
- Flavonol-rich dark cocoa significantly decreases plasma endothelin-1 and improves cognition in urban children
- Food antioxidants and Alzheimer’s disease
- Food, polyphenols and neuroprotection
- Forestalling the Epidemics of Parkinson’s Disease Through Plant-Based Remedies
- Formation of the 42-mer Amyloid 𝜷 Radical and the Therapeutic Role of Superoxide Dismutase in Alzheimer’s Disease
- Formulation development and optimization of novel drug delivery systems for the treatment of alzheimers disease
- Free radical scavenging activity and qualitative analysis of polyphenols by RP-HPLC in the flowers of Couroupita guianensis Abul.
- Free radical–mediated damage to brain in Alzheimer’s disease: role of acrolein and preclinical promise of antioxidant polyphenols
- Free radicals and polyphenols: The redox chemistry of Neurodegenerative diseases
- From the baker to the bedside: yeast models of Parkinson’s disease
- Fruit and vegetable intake and its association with dementia in the English Longitudinal Study of Ageing
- Fruit polyphenols and their effects on neuronal signaling and behavior in senescence
- Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer’s disease
- Functions of flavonoids in the central nervous system: astrocytes as targets for natural compounds
- Future Therapeutic Perspectives into the Alzheimer’s Disease Targeting the oxidative stress Hypothesis
- Gallotannins and Tannic Acid: First Chemical Syntheses and In Vitro Inhibitory Activity on Alzheimer’s Amyloid β‐Peptide Aggregation
- Gene-environment interaction research and transgenic mouse models of Alzheimer’s disease
- GENERAL PRACTITIONER’S APPROACH TO DIAGNOSIS, DISCLOSURE AND MANAGEMENT OF dementia IN THE
- Genetics of iron regulation and the possible role of iron in Parkinson’s disease
- Genistein ameliorates learning and memory deficits in amyloid β (1–40) rat model of Alzheimer’s disease
- Ginger components as anti-Alzheimer drugs: focus on drug design
- Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer’s dementia in a randomized placebo‐controlled double‐blind study
- Ginkgo biloba as an alternative medicine in the treatment of anxiety in dementia and other psychiatric disorders
- Ginkgo biloba extract in Alzheimer’s disease: from action mechanisms to medical practice
- Gold Nanoparticles and Peptoids as Novel Inhibitors of Amyloid Beta Aggregation in Alzheimer’s Disease
- Gold nanoparticles and peptoids as novel inhibitors of Aβ aggregation in Alzheimer’s disease
- Gold Nanoparticles in Diagnosis and Treatment of Alzheimer’s Disease
- Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer’s disease
- Green Tea confers Protection on the Retina in MPTP Mice Model of Parkinson’s Disease
- Green tea intake and risks for dementia, Alzheimer’s disease, mild cognitive impairment, and cognitive impairment: A systematic review
- Green tea polyphenol (–)‐epigallocatechin‐3‐gallate induces neurorescue of long‐term serum‐deprived PC12 cells and promotes neurite outgrowth
- Green tea polyphenol (–)‐epigallocatechin‐3‐gallate prevents N‐methyl‐4‐phenyl‐1,2,3,6‐
tetrahydropyridine‐induced dopaminergic neurodegeneration - Green tea polyphenol (–)‐epigallocatechin‐3‐gallate promotes the rapid protein kinase C‐and proteasome‐mediated degradation of Bad: implications for …
- Green tea polyphenols enhance sodium nitroprusside‐induced neurotoxicity in human neuroblastoma SH‐SY5Y cells
- Green tea polyphenols prevent Parkinson’s disease: in vitro and in vivo studies
- GRP78/BIP/HSPA5 as a Therapeutic Target in Models of Parkinson’s Disease: A Mini Review
- Gut microbiota mediated allostasis prevents stress-induced neuroinflammatory risk factors of Alzheimer’s disease.
- Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review
- Health benefits of nongallated and gallated flavan-3-ols: a prospectus
- Health effects of foods rich in polyphenols
- Healthy Eating to Reduce the Risk of Dementia
- Hepatoprotective effects of apple polyphenol extract on aluminum-induced liver oxidative stress in the rat
- Herbal treatment of Parkinsonism: a review
- Herbs and dementia: a focus on Chinese and other traditional herbs
- Herbs and Nutrients for Neurologic Disorders: Treatment Strategies for Alzheimer’s, Parkinson’s, Stroke, Multiple Sclerosis, Migraine, and Seizures
- Hesperetin, a citrus flavonoid, attenuates LPS-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4/NF-κB signaling
- Hesperidin, a citrus flavonoid, protects against l-methionine-induced hyperhomocysteinemia by abrogation of oxidative stress, endothelial dysfunction and …
- Heterogeneity in gut microbiota drive polyphenol metabolism that influences α-synuclein misfolding and toxicity
- High concentrations of a urinary biomarker of polyphenol intake are associated with decreased mortality in older adults
- Highly Significant Scaffolds to Design and Synthesis Cholinesterase Inhibitors as Anti-Alzheimer Agents
- Hippocampal neurogenesis in Alzheimer’s disease: is there a role for dietary modulation?
- Histological Evidence Of The Effect Of Oil Palm Phenolics In Atherogenic Diet Induced Rat Model Of Alzheimer’s Disease
- HPLC-DAD fingerprinting analysis, antioxidant activities of Tithonia diversifolia (Hemsl.) A. Gray leaves and its inhibition of key enzymes linked to Alzheimer’s …
- HPLC-PDA isolation and LC-MS/MS detection of an acetylcholinesterase inhibitory flavonoid from Tephrosia purpurea (L.) Pers. in zebrafish brain
- Human Tau Isoform Aggregation and Selective Detection of Misfolded Tau from Post-Mortem Alzheimer’s Disease Brains
- Hypericum perforatum improve memory and learning in Alzheimer’s model:(experimental study in mice)
- Hypericum perforatum phenolic compounds: protective role in the toxicity induced by heterologous expression of α-synuclein and huntingtin in yeast cells
- Hyperphosphorylation of Tau Protein in Down’s dementia and Alzheimer’s disease: methylation and implications in prevention and therapy
- Identification of 5-methoxyflavone as a novel DNA polymerase-beta inhibitor and neuroprotective agent against beta-amyloid toxicity
- Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer’s disease
- Identification of polyphenolic compounds and black tea extract as potent inhibitors of lipid membrane destabilization by Aβ 42 aggregates
- IFN-γ and TNF-α are involved during Alzheimer disease progression and correlate with nitric oxide production: a study in Algerian patients
- Il trattamento con RSV e l’espressione transgenica di PGC-1α proteggono i neuroni dopaminergici nel modello MPTP murino del morbo di Parkinson.
- Immuno-modulatory effects of microbial metabolites of flavan-3-ols and dimeric procyanidins
- Impact of Diet on the Pathogenesis of Alzheimer’s Disease
- Impact of flavonoids on cellular and molecular mechanisms underlying age-related cognitive decline and neurodegeneration
- Impact of heat treatment on selected vegetables: bioaccessibility of (poly) phenolic compounds after in vitro gastrointestinal digestion and colonic microbiota …
- Impact of plant-derived flavonoids on Neurodegenerative diseases
- Implication of green tea as a possible therapeutic approach for Parkinson disease
- Implications for Degenerative Disorders: Antioxidative Activity, Total Phenols, Flavonoids, Ascorbic Acid, β-Carotene and β-Tocopherol in Aloe vera
- Implications of polyphenols on endogenous antioxidant defense systems in human diseases
- Improved mitochondrial function in brain aging and Alzheimer disease-the new mechanism of action of the old metabolic enhancer piracetam
- In search of therapeutic solutions for Alzheimer’s disease
- In silico investigation of the pharmacological mechanisms of beneficial effects of Ginkgo biloba L. on Alzheimer’s Disease
- In silico studies applied to natural products with potential activity against Alzheimer’s disease
- In vitro anti-nitrosative, antioxidant, and cytotoxicity activities of plant flavonoids: a comparative study
- In vitro antioxidant activity and total phenolic content of ethanolic leaf extract of Stevia rebaudiana Bert.
- In vitro antioxidant, anti-diabetes, anti-dementia, and inflammation inhibitory effect of Trametes pubescens fruiting body extracts
- In vitro enzyme inhibition potentials and antioxidant activity of synthetic flavone derivatives
- In vitro evaluation of extracts from Mentha species for potential treatment of Alzheimer’s disease
- In vitro peroxynitrite scavenging activity of 6-hydroxykynurenic acid and other flavonoids fromGingko biloba yellow leaves
- In vivo antioxidant activity of total flavonoids from indocalamus leaves in aging mice caused by D-galactose
- In Vivo Characterization of CLR01, an Aggregation and Toxicity Inhibitor, with anAlzheimer’s Disease Focus
- In Vivo Imaging Agents Based on flavonoids for Amyloid’s Plaques in the Brains of Patients with Alzheimer’s Disease
- In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial
- In-depth investigation of the binding of flavonoid taxifolin with bovine hemoglobin at physiological pH: Spectroscopic and molecular docking studies
- In-Vitro Assessment Of Phenolic, Flavonoid, Flavonolic Contents And Antioxidant Activities Of Plant Pleurotus Ostreatus For Neurodegenerative Disorders
- In-vitro cholinesterase inhibitory activity of dry fruit extract of Phyllanthus emblica relevant to the treatment of Alzheimer’s disease
- In-vitro evaluation of acetylcholinesterase inhibition and antioxidant activity of selected Palestinian medicinal plants: Implications for Alzheimer’s disease …
- In-Vitro Evaluation of Cholinesterase Inhibitory and Antioxidant Activities of Tamarindus indica for the Treatment of Alzheimer’s Disease
- In-vitro screening of acetylcholinesterase inhibitory activity of extracts from Palestinian indigenous flora in relation to the treatment of Alzheimer’s disease
- In‐vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer’s disease
- Indian Herbal Medicines used for Treatment of Dementia: An Overview
- Indian herbs and their therapeutic potential against Alzheimer’s Disease and other neurological disorders
- Indoleamine 2, 3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer’s disease hippocampus
- Induction of neuronal differentiation of murine N2a cells by two polyphenols present in the mediterranean diet mimicking neurotrophins activities: resveratrol and …
- Inflammaging as a prodrome to Alzheimer’s disease
- Inflammation in Alzheimer’s Disease, and Prevention with Antioxidants and Phenolic Compounds–What Are the Most Promising Candidates?
- Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications
- Inflammation: role in Parkinson’s disease and target for therapy
- Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons: possible relevance to the etiology of Parkinson’s disease
- INFLUENCE OF EXTRACT AND PHENOL GLYCOSIDES FROM ROSE PETALS ON THE FIBRILS OF AMYLOID PEPTIDE Aβ (1-42). STUDY BY …
- Influence of hesperidin combined with Sinemet on genetical and biochemical abnormalities in rats suffering from Parkinson’s disease
- Influence of nitrogen fertilizer micro‐dosing on phenolic content, antioxidant, and anticholinesterase properties of aqueous extracts of three tropical leafy vegetables
- Influences of Diet, Exercise, and Stress on Hippocampal Health in Depression and Alzheimer’s Disease
- inhibition and antioxidant activity of selected Palestinian medicinal plants: Implications for Alzheimer’s disease therapy
- Inhibition and disaggregation of α‐synuclein oligomers by natural polyphenolic compounds
- Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism
- Inhibition of early upstream events in prodromal Alzheimer’s disease by use of targeted antioxidants
- Inhibition of Hepatic Insulin Resistance by Licorice flavonoids as Mediated by PTP1B Repression
- Inhibition of Rat Prostate Testosterone 5α-Reductase Activity by Isoflavonoids
- Inhibition of α-Synuclein contributes to the ameliorative effects of dietary flavonoids luteolin on arsenite-induced apoptotic cell death in the dopaminergic PC12 cells
- Inhibitory Effect of a flavonoid Dihydromyricetin against Aβ40 Amyloidogenesis and Its Associated Cytotoxicity
- Inhibitory Effects of Bombusae concretio Salicea on Neuronal Secretion of Alzheimer’s β-Amyloid Peptides, a Neurodegenerative Peptide
- Inhibitory Effects of Isoflavonoids on Rat Prostate Testosterone 5α-Reductase
- Inhibitory Mechanism for Amyloid β42 Aggregation by Catechol-type Flavonoids
- Inhibitory potential of plant secondary metabolites against Parkinsonian drug targets: Relevance to pathophysiology, and motor and non-motor behavioural …
- Inhibitory properties of phenolic compounds against enzymes linked with human diseases
- Insights on Metal Ions and Misfolded Proteins in Alzheimer’s Disease Using flavonoid Derivatives and X-ray Fluorescence Microscopy.
- Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance
- Intake of flavonoids and risk of dementia
- Intake of flavonoids and risk of dementia
- Interaction between 24‐hydroxycholesterol, oxidative stress, and amyloid‐β in amplifying neuronal damage in Alzheimer’s disease: three partners in crime
- Interaction between flavonoids and the blood–brain barrier: in vitro studies
- Interaction of polyphenols with other food components as a means for their neurological health benefits
- Interaction of α-synuclein with Rhus typhina tannin–Implication for Parkinson’s disease
- Interplay between Alpha-Synuclein and oxidative stress in Parkinson´ s Disease Cell Models
- Intranasal therapeutic strategies for management of Alzheimer’s disease
- Investigating blood plasma levels of cytokines and amyloid-β as potential diagnostic biomarkers for preclinical Alzheimer’s disease
- Investigating the neuroprotective effect of plant (poly) phenols in models of Parkinson´ s disease
- Investigation of an Interaction of flavonoids on the Antioxidant Activity of Alpha Tocopherol
- Investigation of anti-inflammatory compounds from food and plant libraries for use in Alzheimer’s disease
- Investigation of in-vitro antioxidant potential in crotalaria verrucosa along with identification and quantification of its polyphenolic compounds
- Investigational α-synuclein aggregation inhibitors: hope for Parkinson’s disease
- Investigations of anticholinestrase and antioxidant potentials of methanolic extract, subsequent fractions, crude saponins and flavonoids isolated from Isodon …
- Involvement of astrocytes in Alzheimer’s disease from a neuroinflammatory and oxidative stress perspective
- Iridoid Glycosides and Phenolic Glycosides from Buddleja asiatica with Anti-inflammatory and Cytoprotective Activities
- Iridoids and other monoterpenes in the Alzheimer’s brain: Recent development and future prospects
- Iron as a therapeutic target for Parkinson’s disease
- Iron dysregulation in Alzheimer’s disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein …
- Is pharmacological prevention of Alzheimer’s a realistic goal?
- Isoflavones and Alzheimer’s disease: the effects of soy in diet
- Isolation of eupatorin (3′,5-dihydroxy-4′,6,7-
trimethoxyflavone) from Albizia odoratissima and its application for l-tryptophan sensing - Isolation of flavonoides from Artemisia macrocephala anticholinesterase activity: Isolation, characterization and its in vitro anticholinesterse activity supported by …
- Isolation, synthesis, and metabolism of polyphenols: Stilbenoids, gallotannins and ellagitannins
- Kaempferol attenuates cognitive deficit via regulating oxidative stress and neuroinflammation in an ovariectomized rat model of sporadic dementia
- Lamiaceae family plants as a potential anticholinesterase source in the treatment of Alzheimer’s disease
- Lamiaceae phenols as multifaceted compounds: bioactivity, industrial prospects and role of “positive-stress”
- Lavandula stoechas (L) a Very Potent Antioxidant Attenuates dementia in Scopolamine Induced Memory Deficit Mice
- Liberation of copper from amyloid plaques: making a risk factor useful for Alzheimer’s disease treatment
- Lifestyle modifications and nutritional interventions in aging-associated cognitive decline and Alzheimer’s disease
- Lifestyle patterns as a modifiable risk factor for late-life cognitive decline: A narrative review regarding dementia prevention
- Lifestyle-related factors in predementia and dementia syndromes
- Links between insulin resistance, lipoprotein metabolism and amyloidosis in Alzheimer’s Disease
- Lipid Peroxidation and Mitochondrial Dysfunction in Alzheimer’s and Parkinson’s Diseases: Role of Natural Products as Cytoprotective Agents
- Liposomal flavonoid in Combating Age-Related Cerebral Oxidative Damage
- Literature Evidence and ARRIVE Assessment on neuroprotective Effects of Flavonols in Neurodegenerative Diseases’ Models
- Literature Evidence and Arrive Assessment on neuroprotective Effects of Flavonols Quercetin, Rutin and Isoquercitrin in Neurodegenerative Diseases’ Models
- Literature-related discovery: common factors for Parkinson’s disease and Crohn’s disease
- Literature-related discovery: common factors for Parkinson’s Disease and Crohn’s Disease
- Long-term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of Alzheimer’s disease
- Long-term naringin consumption reverses a glucose uptake defect and improves cognitive deficits in a mouse model of Alzheimer’s disease
- Low Phytanic Acid-Concentrated DHA Prevents Cognitive Deficit and Regulates Alzheimer Disease Mediators in an ApoE−/− Mice Experimental Model
- Low-Molecular Weight Metabolites from Polyphenols as Effectors for Attenuating Neuroinflammation
- Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer’s Disease
- Macronutrients, aluminium from drinking water and foods, and other metals in cognitive decline and dementia
- Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent
- Management of cognitive determinants in senile dementia of Alzheimer’s type: therapeutic potential of a novel polyherbal drug product
- Management of oxidative stress and other pathologies in Alzheimer’s disease
- Mangiferin: a multipotent natural product preventing neurodegeneration in Alzheimer’s and Parkinson’s disease models
- Mannosylated liposomal flavonoid in combating age-related ischemia–reperfusion induced oxidative damage in rat brain
- MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide
- Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease
- Mechanisms of aging and potential role of selected polyphenols in extending healthspan
- Mechanisms of dietary flavonoid action in neuronal function and neuroinflammation
- Mechanisms of neuroprotection by polyphenols
- Mechanistic description of natural herbs in the treatment of dementia: A systematic review
- Medical management of Parkinson’s disease: focus on neuroprotection
- Medicinal chemistry approaches for the treatment and prevention of Alzheimer’s disease
- Medicinal plants and Alzheimer’s disease: Integrating ethnobotanical and contemporary scientific evidence
- Medicinal plants and dementia therapy: herbal hopes for brain aging?
- Medicinal plants as protective strategies against Parkinson’s disease
- Medicinal plants from northeastern Brazil against Alzheimer’s disease
- Medicinal Plants from Northeastern Brazil against Alzheimer’s Disease
- Medicinal plants of Brazil and Alzheimer’s disease: Evolution in traditional use and pre-clinical studies
- Medicinal Plants with Acetylcholinesterase Inhibitory Activity: Therapeutic Potential of Brazilian Plants for the Treatment of Alzheimer’s Disease
- Medicinal Plants, Phytochemicals and Alzheimer’s
- Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: an update on current evidence and …
- Mediterranean and MIND diets containing olive biophenols reduces the prevalence of Alzheimer’s disease
- Mediterranean diet and risk for Alzheimer’s disease
- Mediterranean Diet as a Potential Strategy to Reduce Cognitive Decline and dementia in Elderly
- Mediterranean diet in predementia and dementia syndromes
- Mediterranean diet, cognitive function, and dementia: a systematic review
- Mediterranean diet: The role of long-chain ω-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and wine; probiotics and vitamins …
- Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson’s disease
- Metabolic and immune risk factors for dementia and their modification by flavonoids: New targets for the prevention of cognitive impairment?
- Metabolic links between diabetes and Alzheimer’s disease
- Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease
- Metabolomics analysis of Xanthoceras sorbifolia husks protection of rats against Alzheimer’s disease using liquid chromatography mass spectrometry
- Metal Binding of flavonoids and Their Distinct Inhibition Mechanisms Toward the Oxidation Activity of Cu2+–β-Amyloid: Not Just Serving as Suicide Antioxidants!
- Metal Chelation Therapy and Parkinson’s Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or …
- Metal chelation, radical scavenging and inhibition of Aβ42 fibrillation by food constituents in relation to Alzheimer’s disease
- Metal dyshomeostasis and inflammation in Alzheimer’s and Parkinson’s diseases: possible impact of environmental exposures
- Metal dysregulation in the pathogenesis of Alzheimers disease An experimental study in rat brain and cultured neuroblastoma cells
- Metal ions and metal complexes in Alzheimer’s disease
- Metals and amyloid‐β in Alzheimer’s disease
- Methanolic extract of Hibiscus asper leaves improves spatial memory deficits in the 6-hydroxydopamine-lesion rodent model of Parkinson’s disease
- Methylglyoxal, glyoxal, and their detoxification in Alzheimer’s disease
- MICE MODEL OF Parkinson’s DISEASE
- Microwave assisted extraction of flavonoids from cultivated Epimedium sagittatum: Extraction yield and mechanism, antioxidant activity and chemical composition
- Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study
- MIND food and speed of processing training in older adults with low education, the MINDSpeed Alzheimer’s disease prevention pilot trial
- Mitigating Alzheimer’s disease with natural polyphenols: a review
- Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer’s disease
- Mitochondria as potential targets in Alzheimer disease therapy: An update
- Mitochondria as targets for neuronal protection against excitotoxicity: a role for phenolic compounds?
- Mitochondria in neuroprotection by phytochemicals: bioactive polyphenols modulate mitochondrial apoptosis system, function and structure
- Mitochondria-targeted protective compounds in Parkinson’s and Alzheimer’s diseases
- Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer’s disease
- Mitochondrial cascade hypothesis of Alzheimer’s disease: myth or reality?
- Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer’s Disease?
- Mitochondrial dysfunction in Parkinson’s disease: pathogenesis and neuroprotection
- Mitochondrial dysfunction—a pharmacological target in Alzheimer’s disease
- Mitochondrial dysfunction: cause and consequence of Alzheimer’s
- Mitochondrial dysfunction: cause and consequence of Alzheimer’s disease
- Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer’s disease—therapeutic aspects
- Mitochondrial dysfunction: the first domino in brain aging and Alzheimer’s disease?
- Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols
- Mitochondrial Therapeutic Approaches in Parkinson’s Disease
- Moderate consumption of Cabernet Sauvignon attenuates Aβ neuropathology in a mouse model of Alzheimer’s disease
- Modulating Effect of Diet on Alzheimer’s Disease
- Modulation of Alzheimer-like Pathology in Type 2 Diabetic Rats via Grape Seed or Ginseng Extracts
- Modulation of endogenous antioxidant system by wine polyphenols in human disease
- Modulation of mitochondrial calcium as a pharmacological target for Alzheimer’s disease
- Modulation of multiple neuroinflammatory signalling pathways by the dietary glycosidic flavonoid tiliroside
- MODULATION OF NEUROINFLAMMATION BY MEDICINAL HERBS AND FLAVONOIDS
- Modulation of Nrf2 by olive oil and wine polyphenols and neuroprotection
- Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and Neurodegenerative disorders
- Modulation of Pro-inflammatory Mediators by Eugenol in AlCl3 Induced dementia in Rats
- Molecular characterization of multi-targets by bis (7)-tacrineat amyloid β cascade associated with Alzheimer’s disease
- Molecular Mechanism of the Inhibition of EGCG on the Alzheimer Aβ1–42 Dimer
- Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green tea polyphenols
- Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer’s disease
- Molecular mechanisms underlying the flavonoid-induced inhibition of α-synuclein fibrillation
- Molecular pathology and pharmacogenomics in Alzheimer’s disease: polygenic-related effects of multifactorial treatments on cognition, anxiety, and depression
- Molecular pharmacology of rosmarinic and salvianolic acids: Potential seeds for Alzheimer’s and vascular dementia drugs
- Molecular study of cell culture models of Parkinson’s disease and Huntington’s disease.
- Molecular targets in Alzheimer’s disease: from pathogenesis to therapeutics
- Monoamine oxidase and α-synuclein as targets in Parkinson’s disease therapy
- Monoamine Oxidase B and Free Radical Scavenging Activities of Natural flavonoids in Melastoma candidum D. Don
- MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies
- MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies
- Mucuna pruriens seeds in treatment of Parkinson’s disease: pharmacological review
- Mulberry fruit extract protects against memory impairment and hippocampal damage in animal model of vascular dementia
- Multi-target directed drugs as a modern approach for drug design towards Alzheimer’s disease: an update
- Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer’s disease
- Multi-target-directed ligands and other therapeutic strategies in the search of a real solution for Alzheimer’s disease
- Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer’s disease
- Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer’s disease drugs
- Multifunctional neuroprotective–neurorescue drugs for Parkinson’s disease
- Multiple pharmacological activities of Caesalpinia crista against aluminium-induced neurodegeneration in rats: Relevance for Alzheimer’s disease
- Multipotent natural agents to combat Alzheimer’s disease. Functional spectrum and structural features1
- Na+‐K+‐ATPase, a potent neuroprotective modulator against Alzheimer disease
- Nano-delivery systems for encapsulation of dietary polyphenols: An experimental approach for Neurodegenerative diseases and brain tumors
- Nano-encapsulation of a natural polyphenol, green tea catechins: way to preserve its antioxidative potential
- Nanoformulations of polyphenols for prevention and treatment of cardiovascular and metabolic disorders
- Nanolipidic Carriers as Potential Drug Delivery Vehicles in Alzheimer’s Disease
- Nanoparticle formulations in the diagnosis and therapy of Alzheimer’s disease
- Nanoparticles as nanocarriers of resveratrol for Alzheimer’s disease
- Nanotechnology and Alzheimer’s Disease: What has been Done and What to Do’
- Nanotechnology based Theranostic approaches in Alzheimer’s disease management: current status and future perspective
- Nanotechnology to improve the Alzheimer’s disease therapy with natural compounds
- Nanotherapeutic strategies for the treatment of Alzheimer’s disease
- Nardostacys Jatamansi DC Protects from the loss of memory and cognition deficits in sleep deprived Alzheimer’s disease (Ad) mice model
- Naringenin ameliorates Alzheimer’s disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-
streptozotocin … - Naringin ameliorates memory deficits in experimental paradigm of Alzheimer’s disease by attenuating mitochondrial dysfunction
- Natural Antioxidants in Dementia: An Overview
- Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer’s disease–a translational perspective
- Natural compounds and their derivatives as multifunctional agents for the treatment of alzheimer disease
- Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer’s Disease
- Natural compounds for Alzheimer’s disease therapy: a systematic review of preclinical and clinical studies
- Natural Compounds for the Management of Parkinson’s Disease and Attention-Deficit/
Hyperactivity Disorder - Natural Neuroprotectives for the Management of Parkinson’s Disease
- Natural phenolic compounds as therapeutic and preventive agents for cerebral amyloidosis
- Natural phytochemicals in the treatment and prevention of dementia: An overview
- Natural Phytoestrogens: A Class of Promising neuroprotective Agents for Parkinson Disease
- Natural plant-derived acetylcholinesterase inhibitors: Relevance for Alzheimer’s disease
- Natural polyphenols against Neurodegenerative disorders: potentials and pitfalls
- Natural polyphenols binding to amyloid: A broad class of compounds to treat different human amyloid diseases
- Natural polyphenols effects on protein aggregates in Alzheimer’s and Parkinson’s prion-like diseases
- Natural polyphenols in the treatment of Alzheimer’s disease
- Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation
- Natural Product Chemical Probe Discovery against Parkinson’s Disease
- Natural product formulations for the prevention and treatment of Alzheimer’s disease: a patent review
- Natural product polyphenols of relevance to human health
- Natural products against Alzheimer’s disease: Pharmaco-therapeutics and biotechnological interventions
- Natural products and derivatives affecting neurotransmission relevant to Alzheimer’s and Parkinson’s disease
- Natural products and their derivatives as multifunctional ligands against Alzheimer’s disease
- Natural products as a source of Alzheimer’s drug leads
- Natural products as promising drug candidates for the treatment of Alzheimer’s disease: molecular mechanism aspect
- Natural products combating neurodegeneration: Parkinson’s disease
- Natural Products for the Treatment of Alzheimer’s Disease: Present and Future Expectations
- Natural Products for Treatment of Alzheimer’s Disease
- Natural products in Alzheimer’s disease therapy: would old therapeutic approaches fix the broken promise of modern medicines?
- Natural Products-Based Drugs: Potential Therapeutics against Alzheimer’s Disease and other Neurological Disorders
- Natural stilbenes effects in animal models of Alzheimer’s disease
- Natural Therapeutics for Alzheimer’s Disease
- Naturally Inspired Privileged Structures in Drug Discovery: Multifunctional Compounds for Alzheimer’s Disease Treatment
- Nature as a source of metabolites with cholinesterase‐inhibitory activity: an approach to Alzheimer’s disease treatment
- neuro Protective Role of Selected medicinal Plant In Alzheimers Disease Design of Novel Drugs
- Neuro-nutrients as anti-Alzheimer’s disease agents: A critical review
- Neurobiological aspects of Alzheimer’s disease
- Neurobiological effects of Hyperforin and its potential in Alzheimer’s disease therapy
- Neurochemical correlates of dementia severity in Alzheimer’s disease: relative importance of the cholinergic deficits
- Neurocognitive improvement through plant food bioactives: A particular approach to Alzheimer’s disease
- Neurodegenerative diseases: might citrus flavonoids play a protective role?
- Neurogenesis and neuroprotection in postischemic brain neurodegeneration with Alzheimer phenotype: is there a role for curcumin
- Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer’s disease
- Neurogenic traditional Chinese medicine as a promising strategy for the treatment of Alzheimer’s disease
- Neuroinflammation in Alzheimer’s disease: the preventive and therapeutic potential of polyphenolic nutraceuticals
- Neuroinflammatory mechanisms in Parkinson’s disease: potential environmental triggers, pathways, and targets for early therapeutic intervention
- Neuroinflammatory processes in cognitive disorders: Is there a role for flavonoids and n-3 polyunsaturated fatty acids in counteracting their detrimental effects?
- Neurological mechanisms of green tea polyphenols in Alzheimer’s and Parkinson’s diseases
- Neuronal death in Alzheimer’s disease and therapeutic opportunities
- Neuronutrition and Alzheimer’s disease
- Neuropharmacological Activity of Apium graveolens L. and its neuroprotective Effect on MPTP-Induced Parkinson-Like Symptoms
- Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin—a mini-review
- Neuroprotection by natural polyphenols: molecular mechanisms
- Neuroprotection in Alzheimer Disease
- Neuroprotection of brain-targeted bioactive dietary artoindonesianin O (AIO) from mulberry on rat neurons as a novel intervention for Alzheimer’s disease
- Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway
- neuroprotective actions of flavones and flavonols: mechanisms and relationship to flavonoid structural features
- neuroprotective actions of flavonoids
- neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice
- neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson’s disease therapeutics
- neuroprotective effect and antioxidant activity of Passiflora edulis fruit flavonoid fraction, aqueous extract, and juice in aluminum chloride-induced Alzheimer’s …
- neuroprotective effect of blackberry (Rubus sp.) polyphenols is potentiated after simulated gastrointestinal digestion
- neuroprotective effect of brassica oleracea sprouts crude juice in a cellular model of Alzheimer’s disease
- neuroprotective effect of cocoa flavonids on in vitro oxidative stress
- neuroprotective effect of EGb761® and low-dose whole-body γ-irradiation in a rat model of Parkinson’s disease
- neuroprotective effect of ellagic acid against chronically scopolamine induced Alzheimer’s type memory and cognitive dysfunctions: possible behavioural and …
- neuroprotective effect of flavonoids via up-regulation of Nrf2-ARE pathway, in MPP+-induced PC12 cells
- neuroprotective Effect of Flavonoids: A Systematic Review
- neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson’s disease
- neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer’s …
- neuroprotective effect of hesperidin on aluminium chloride induced Alzheimer’s disease in Wistar rats
- neuroprotective effect of naringin, a dietary flavonoid against 3-nitropropionic acid-induced neuronal apoptosis
- neuroprotective effect of natural products against Alzheimer’s disease
- neuroprotective effect of olive oil polyphenols in Alzheimer’s disease
- neuroprotective effect of phytic acid in Parkinson’s disease
- neuroprotective effects associated with wine and its phenolic constituents
- neuroprotective effects of amantadine–flavonoid conjugates
- neuroprotective effects of citrus Fruit-Derived flavonoids, nobiletin and Tangeretin in Alzheimer’s and Parkinson’s Disease
- neuroprotective effects of digested polyphenols from wild blackberry species
- neuroprotective effects of epigallocatechin gallate in cell culture and animal models of Parkinson’s disease
- neuroprotective effects of fisetin in Alzheimer’s and Parkinson’s Diseases: From chemistry to medicine
- neuroprotective effects of naturally occurring polyphenols on quinolinic acid‐induced excitotoxicity in human neurons
- neuroprotective effects of phenolic and carboxylic acids on oxidative stress-induced toxicity in human neuroblastoma SH-SY5Y cells
- neuroprotective Effects of Polyphenols
- neuroprotective Effects of Polyphenols in Aging and Age‐Related Neurological Disorders
- neuroprotective Effects of Quercetin in Alzheimer’s Disease
- neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma
- neuroprotective effects of resveratrol in Alzheimer disease pathology
- neuroprotective effects of rutin and quercetin flavonoids in glaucium corniculatum methanol and water extracts
- neuroprotective effects of selected microbial-derived phenolic metabolites and aroma compounds from wine in human sh-sy5y neuroblastoma cells and their …
- neuroprotective mechanisms of resveratrol in Alzheimer’s disease: role of SIRT1
- neuroprotective natural products for the treatment of Parkinson’s disease by targeting the autophagy–lysosome pathway: A systematic review
- neuroprotective potential of withania somnifera in rotenone induced parkinsonism in mice
- neuroprotective properties of a standardized extract from Myracrodruon urundeuva Fr. All.(Aroeira-Do-Sertao), as evaluated by a Parkinson’s disease model in rats
- neuroprotective properties of dietary polyphenols in Parkinson’s disease
- neuroprotective Properties of Partridgeberry (Vaccinium vitis-idaea L. var. minus Lodd) Polyphenols
- neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson’s disease
- neuroprotective role of antioxidant and pyranocarboxylic acid derivative against AlCl3 induced Alzheimer’s disease in rats
- neuroprotective Role of Green Tea Polyphenols on the Superior Colliculus in MPTP Mice Model of Parkinson’s Disease
- neuroprotective role of natural polyphenols
- neuroprotective strategies in Parkinson’s disease
- neuroprotective Strategies in Parkinson’s Disease Using the Models of 6‐Hydroxydopamine and MPTPa
- neuroprotective Strategies in Parkinson’s Disease Using the Models of 6‐Hydroxydopamine and MPTPa
- neuroprotective strategies to prevent and treat Parkinson’s disease based on its pathophysiological mechanism
- neuroprotective therapies for Alzheimer’s disease
- Neurosupportive role of vanillin, a natural phenolic compound, on rotenone induced neurotoxicity in SH-SY5Y neuroblastoma cells
- Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
- New acetylcholinesterase inhibitors for Alzheimer’s disease
- New methodology for the biomimetic synthesis of Flavan-3, 4-diols and derivatives
- NF-κB-Mediated Neuroinflammation in Parkinson’s Disease and Potential Therapeutic Effect of Polyphenols
- Nitric oxide mediates neurovascular coupling in the brain effect of polyphenols in animal models of Alzheimer’s disease
- Nonpeptide neurotrophic agents useful in the treatment of Neurodegenerative diseases such as Alzheimer’s disease
- Nonpharmacological Modulation of Chronic Inflammation in Parkinson’s Disease: Role of Diet Interventions
- Nonsteroidal antiinflammatory drug use and the risk for Parkinson’s disease
- Nootropic and anti-Alzheimer’s actions of medicinal plants: molecular insight into therapeutic potential to alleviate Alzheimer’s neuropathology
- Nootropic Medicinal Plants: Therapeutic Alternatives for Alzheimer’s disease
- Novel benzylidenephenylpyrrolizinone
s with pleiotropic activities potentially useful in Alzheimer’s disease treatment - Novel chelators targeting cell cycle arrest, acetylcholinesterase, and monoamine oxidase for Alzheimer’s therapy
- Novel disease-modifying therapeutics for the treatment of Alzheimer’s disease
- Novel Mannitol-Based Small Molecules for Inhibiting Aggregation of α-Synuclein Amyloids in Parkinson’s Disease
- Novel multifunctional anti-Alzheimer drugs with various CNS neurotransmitter targets and neuroprotective moieties
- Novel neuroprotective Therapies for Alzheimer’s and Parkinsons’s Disease
- Novel photoaffinity probes of homoisoflavonoids for target identification of retinal neovascularization
- Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer’s disease
- Novel regimen through combination of memantine and tea polyphenol for neuroprotection against brain excitotoxicity
- Novel tacrine-scutellarin hybrids as multipotent anti-Alzheimer’s agents: Design, synthesis and biological evaluation
- Novel tactics for neuroprotection in Parkinson’s disease: role of antibiotics, polyphenols and neuropeptides
- Novel targets for parkinsonism-depression comorbidity
- Novel therapeutic strategies for dementia
- Novel Therapeutics in Alzheimer’s Disease
- Nutraceutical potential of phenolics from′ brava′ and′ mansa′ extra-virgin olive oils on the inhibition of enzymes associated to Neurodegenerative disorders in …
- Nutraceutical Potential of Phenolics fromBrava´ andMansa´ Extra-Virgin Olive Oils on the Inhibition of Enzymes Associated to Neurodegenerative Disorders in …
- Nutraceuticals and amyloid Neurodegenerative diseases: a focus on natural phenols
- Nutraceuticals and their preventive or potential therapeutic value in Parkinson’s disease
- Nutraceuticals in cognitive impairment and Alzheimer’s
- Nutraceuticals in cognitive impairment and Alzheimer’s disease
- Nutraceuticals in the Prevention or Treatment of Parkinson’s Disease
- Nutraceuticals Neuroprotect Naturally: Alzheimer’s disease, Parkinson’s disease, Stroke and Major Depressive Disorder
- Nutraceuticals: a novel concept in prevention and treatment of Alzheimer’s disease and related disorders
- Nutraceuticals: an emerging therapeutic approach against the pathogenesis of Alzheimer’s disease
- Nutraceuticals: dietary flavonoids
- Nutrients in the Prevention of Alzheimer’s Disease
- Nutrition and AGE-ing: Focusing on Alzheimer’s Disease
- Nutrition and the risk for Parkinson’s disease: review of the literature
- Nutrition and the risk of Alzheimer’s disease
- Nutrition increases Survival and Reverses NAFLD and Alzheimer’s disease
- Nutrition Society Silver Medal Lecture Beyond antioxidants: the cellular and molecular interactions of flavonoids and how these underpin their actions on the brain
- Nutrition: Review on the possible treatment for Alzheimer’s disease
- Nutritional and pharmacological strategies to regulate microglial polarization in cognitive aging and Alzheimer’s disease
- Nutritional approaches to combat oxidative stress in Alzheimer’s disease
- Nutritional approaches to modulate oxidative stress in Alzheimer’s disease
- Nutritional contributions to dementia prevention: main issues on antioxidant micronutrients
- Nutritional habits, risk, and progression of Parkinson disease
- Nutritional prevention of cognitive decline and dementia
- O-Methylated flavonoid Isorhamnetin Protects against oxidative stress via Activation of Nrf2 and Target Gene Expression
- Oil palm phenolics inhibit the in vitro aggregation of β-amyloid peptide into oligomeric complexes
- Old age-associated phenotypic screening for Alzheimer’s disease drug candidates identifies sterubin as a potent neuroprotective compound from Yerba santa
- Olive biophenols reduces Alzheimer’s pathology in SH-SY5Y cells and APPswe mice
- Olive polyphenols: New promising agents to combat aging-associated neurodegeneration
- Omics and Epigenetics of Polyphenol-Mediated Neuroprotection: The Curcumin Perspective
- On the role of synthesized hydroxylated chalcones as dual functional amyloid-β aggregation and ferroptosis inhibitors for potential treatment of Alzheimer’s disease
- ON THE THERAPEUTIC PROPERTIES OF NATURALLY OCCURRING FLAVONOID-QUERCETIN: A MAGICAL THERAPEUTIC AGENT
- One‐compound‐multiple‐targets strategy to combat Alzheimer’s disease
- Original Research Phenolics, antioxidant and anti-inflammatory activities of Melia azedarachextracts
- Orobol: An Isoflavone Exhibiting Regulatory Multifunctionality against Four Pathological Features of Alzheimer’s Disease
- Orthosiphon stamineus improves memory in scopolamine-induced amnesia model of cholinergic hypothesis of Alzheimer’s disease
- Outsmarting Alzheimer’s: What You Can Do to Reduce Your Risk
- Overview of Alzheimer’s disease and some therapeutic approaches targeting Aβ by using several synthetic and herbal compounds
- Overviews of biological importance of quercetin: A bioactive flavonoid
- Oxidant/antioxidant imbalance and the risk of Alzheimer’s disease
- Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8‐hydroxyguanine levels in substantia nigra
- Oxidative modification of vesicular transporters in an animal model of Alzheimer’s disease
- oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agents
- oxidative stress and amyloid beta toxicity in Alzheimer’s disease: intervention in a complex relationship by antioxidants
- oxidative stress and inflammation: what polyphenols can do for us?
- oxidative stress and neuroinflammation in Alzheimer’s disease and amyotrophic lateral sclerosis: From biology to therapeutic strategies
- oxidative stress events and neuronal dysfunction in Alzheimer’s disease: focus on APE1/Ref-1-mediated survival strategies
- oxidative stress in Alzheimer patients in different stages of the disease
- oxidative stress in Alzheimer’s Disease: A Review on Emergent Natural Polyphenolic Therapeutics
- oxidative stress in Alzheimer’s disease: implications for prevention and therapy
- oxidative stress in Parkinson’s disease
- oxidative stress in Parkinson’s disease
- oxidative stress in Parkinson’s disease; parallels between current animal models, human studies and cells
- Oxidative stress: a bridge between Down’s syndrome and Alzheimer’s disease
- Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease
- Parkinson’s disease and tea: a quantitative review
- Parkinson’s Disease Model in vitro and in C. elegans
- Parkinson’s Disease-associated LRRK2 Mutation Causes Abnormal Protein Accumulation-related Cytotoxicity
- Parkinson’s disease: from pathogenesis to pharmacogenomics
- Parkinson’s disease: the emerging role of gut dysbiosis, antibiotics, probiotics, and fecal microbiota transplantation
- Partridgeberry polyphenols protect primary cortical and hippocampal neurons against β-amyloid toxicity
- Past and Present Drug Development for Alzheimer’s Disease
- Pelargonidin improves memory deficit in amyloid β25-35 rat model of Alzheimer’s disease by inhibition of glial activation, cholinesterase, and oxidative stress
- Pelargonidin improves passive avoidance task performance in a rat amyloid beta25-35 model of Alzheimer’s disease via estrogen receptor independent pathways
- Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer’s disease
- Pharmacoepigenomic interventions as novel potential treatments for Alzheimer’s and Parkinson’s diseases
- Pharmacogenomics in Alzheimer’s disease
- Pharmacogenomics of Alzheimer’s disease: Novel therapeutic strategies for drug development
- Pharmacokinetics and Tissue Distribution of 14C-Labeled Grape Polyphenols in the Periphery and the Central Nervous System Following Oral Administration
- PHARMACOLOGICAL ACTIVITY OF NATURAL PRODUCTS IN VITRO AND IN ANIMAL MODELS OF Parkinson’s DISEASE AND DEPRESSION
- Pharmacological effects of active components of Chinese herbal medicine in the treatment of Alzheimer’s disease: a review
- PHARMACOLOGICAL EVALUATION OF TRIPHALA CHURNA INSTREPTOZOTOCIN (ICV) INDUCED dementia IN RATS
- Pharmacological Investigation and Unraveling Mechanism of Action ofJasminum sambac Flowers for Predicated Treatment of Alzheimer’s Disease
- Pharmacological manipulation of ataxia-telangiectasia kinase activity as a treatment for Parkinson’s disease
- Pharmacological properties and therapeutic potential of naringenin: a citrus flavonoid of pharmaceutical promise
- PHARMACOLOGY OF OLIVE BIOPHENOLS IN Alzheimer’s DISEASE PREVENTION AND TREATMENT
- Pharmacophore-based drug design of novel potential tau ligands for Alzheimer’s disease treatment
- Pharmacotherapies for Alzheimer’s disease: beyond cholinesterase inhibitors
- Pharmacotherapies for Alzheimer’s Disease: From Natural Compounds to Target Synthetic Drugs
- Phenolic Acid Intake, Delivered Via Moderate Champagne Wine Consumption, Improves Spatial Working Memory Via the Modulation of Hippocampal and Cortical …
- Phenolic acids exert anticholinesterase and cognition-improving effects
- Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity
- Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein
- Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein
- Phenolic composition, antioxidant and enzyme inhibitory activities of acetone, methanol and water extracts of Clinopodium vulgare L. subsp. vulgare L.
- Phenolic compounds and their health benefits: A review
- Phenolic compounds characteristic of the mediterranean diet in mitigating microglia-mediated neuroinflammation
- Phenolic compounds from edible algae: Bioactivity and health benefits
- Phenolic Compounds from the Leaves and Stems of Desmodium Caudatum
- Phenolic compounds in fruits and beverages consumed as part of the mediterranean diet: their role in prevention of chronic diseases
- Phenolic compounds in fruits and beverages consumed as part of the mediterranean diet: their role in prevention of chronic diseases
- Phenolic compounds of green tea: Health benefits and technological application in food
- Phenolic compounds prevent Alzheimer’s pathology through different effects on the amyloid-β aggregation pathway
- Phenolic compounds prevent the oligomerization of α‐synuclein and reduce synaptic toxicity
- Phenolic Compounds with IL-6 Inhibitory Activity from Akebia quinata
- Phenolic content of grapevine leaves (Vitis labrusca var. Bordo) and its neuroprotective effect against peroxide damage
- Phenolic content, enzyme inhibitory and antioxidative activity potentials of Phlomis nissolii and P. pungens var. pungens
- Phenolic contents and bioactive potential of peach fruit extracts
- Phenolic contents, antioxidant and anticholinesterase potentials of crude extract, subsequent fractions and crude saponins from Polygonum hydropiper L
- Phenolic Extracts from Clerodendrum volubile Leaves Inhibit Cholinergic and Monoaminergic Enzymes Relevant to the Management of Some Neurodegenerative …
- Phenolic profile and antioxidative properties of pulp and seeds of Randia monantha Benth
- Phenolic profile of three wild edible mushroom extracts from Ordu, Turkey and their antioxidant properties, enzyme inhibitory activities
- Phenolic, flavonoid contents, anticholinesterase and antioxidant evaluation of Iris germanica var; florentina
- Phenylpropanoids and Alzheimer’s disease: A potential therapeutic platform
- Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson’s disease in mice
- Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer’s disease
- Phosphorylation and sequence dependency of neurofilament protein oxidative modification in Alzheimer disease
- Phyto‐Tacrine Hybrids as Promising Drugs to Treat Alzheimer’s Disease
- Phytochemical and pharmacological properties of flavonols
- Phytochemical Evaluation of Lagerstroemia indica (L.) Pers. Leaves as Anti-Alzheimer’s
- Phytochemicals and cognitive health: Are flavonoids doing the trick?
- Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease
- Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism
- Phytochemicals, Antioxidants, and Cholinesterase Inhibitory Profiles of Elatostema Papillosum Leaves: An Alternative Approach for Management of Alzheimer’s …
- Pinus halepensis essential oil attenuates the toxic Alzheimer’s amyloid beta (1-42)-induced memory impairment and oxidative stress in the rat hippocampus
- PLANT BASED INDIAN TRADITIONAL MEDICINE FOR Neurodegenerative DISEASES-A NOVEL APPROACH TO TREAT ALZHEIMER
- Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson’s Disease Models
- Plant phenolics affect oxidation of tryptophan
- Plant phenolics as functional food ingredients
- Plant polyphenols as dietary antioxidants in human health and disease
- Plant polyphenols as dietary modulators of brain functions
- Plant polyphenols as natural drugs for the management of Down syndrome and related disorders
- Plants as potential sources for drug development against Alzheimer’s disease
- Plants traditionally used in age-related brain disorders (dementia): an ethanopharmacological survey
- Plants with traditional uses and activities, relevant to the management of Alzheimer’s disease and other cognitive disorders
- Plasma antioxidant status in patients with Alzheimer’s disease and cognitively intact elderly: a meta-analysis of case-control studies
- Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson’s disease
- Plasticity of hippocampal synaptic transmission and intrinsic excitability in a mouse model of Alzheimer’s disease
- Polymethoxyflavones: Novel β-secretase (BACE1) inhibitors from citrus peels
- polyphenol amentoflavone affords neuroprotection against neonatal hypoxic‐ischemic brain damage via multiple mechanisms
- polyphenol antioxidants from natural sources and contribution to health promotion
- polyphenol composition, antioxidant and bioplaguicide activities of the solid residue from hydrodistillation of Rosmarinus officinalis L.
- polyphenol compounds and PKC signaling
- polyphenol health effects on cardiovascular and Neurodegenerative disorders: A review and meta-analysis
- polyphenol modulation of blood flow and oxygenation
- polyphenol Pharmacokinetics and Cardiovascular, Cognitive and Exercise Pharmacodynamics following Montmorency Tart Cherry Intake in Humans
- polyphenol stilbenes: molecular mechanisms of defence against oxidative stress and aging-related diseases
- Polyphenol-enriched cocoa protects the diabetic retina from glial reaction through the sirtuin pathway
- Polyphenol-rich Boswellia serrata gum prevents cognitive impairment and insulin resistance of diabetic rats through inhibition of GSK3β activity, oxidative …
- Polyphenol-rich foods in the Mediterranean diet are associated with better cognitive function in elderly subjects at high cardiovascular risk
- Polyphenolic antioxidants and neuronal regeneration
- Polyphenolic Compound from Vitis vinifera L. have Potential for the Alzheimer Disease Treatment
- Polyphenolic compounds for treating Neurodegenerative disorders involving protein misfolding
- Polyphenols and brain health
- Polyphenols and cognitive function
- Polyphenols and health: new and recent advances
- Polyphenols and human health: a review
- Polyphenols and human health: prevention of disease and mechanisms of action
- Polyphenols and inflammation
- Polyphenols and Metabolites Enhance Survival in Rodents and Nematodes—Impact of Mitochondria
- Polyphenols and Neurodegenerative diseases
- Polyphenols and Neurodegenerative Diseases
- Polyphenols and neuroprotection against ischemia and neurodegeneration
- Polyphenols and public health
- Polyphenols and the human brain: plant “secondary metabolite” ecologic roles and endogenous signaling functions drive benefits
- Polyphenols as acetylcholinesterase inhibitors: structural specificity and impact on human disease
- Polyphenols As Natural, Dual-Action Therapeutics For Alzheimer’s Disease
- Polyphenols beyond barriers: a glimpse into the brain
- Polyphenols derived from lychee seed suppress Aβ (1-42)-induced neuroinflammation
- Polyphenols for diabetes associated neuropathy: Pharmacological targets and clinical perspective
- Polyphenols from Food and Natural Products: Neuroprotection and Safety
- Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative
- Polyphenols in dementia: From molecular basis to clinical trials
- Polyphenols in disease: from diet to supplements
- Polyphenols in health and disease: practice and mechanisms of benefits
- Polyphenols in neurodegeneration and neuroendocrine alterations: a metabolomic approach
- Polyphenols in Parkinson’s disease: A systematic review of in vivo studies
- Polyphenols in the Prevention of Alzheimer’s Disease: some food for thought?
- Polyphenols Modulate Alzheimer’s Amyloid Beta Aggregation in a Structure-Dependent Manner
- Polyphenols neuroprotective effect in a Parkinson’s disease yeast model: phosphoproteome alterations
- Polyphenols suppress and modulate inflammation: possible roles in health and disease
- Polyphenols Targeting Brain Cells Longevity, Brain’s Redox Status, and Neurodegenerative Diseases
- Polyphenols-What’s Behind their Antiaging Brain Reputation
- Polyphenols: a diverse class of multi-target anti-HIV-1 agents
- Polyphenols: Food sources and health benefits
- Polyphenols: multipotent therapeutic agents in Neurodegenerative diseases
- Polyphenols: well beyond the antioxidant capacity: gallic acid and related compounds as neuroprotective agents: you are what you eat!
- Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer’s disease
- Pomegranate’s neuroprotective effects against Alzheimer’s disease are mediated by urolithins, its ellagitannin-gut microbial derived metabolites
- Possible involvement of programmed cell death pathways in the neuroprotective action of polyphenols
- Possible role of common spices as a preventive and therapeutic agent for Alzheimer’s disease
- Possible therapeutic role of grape (Vitis vinifera) leaves polyphenolic extract in the regression of aluminium-induced Alzheimer’s disease in rats
- Possible Therapeutic Uses of Salvia triloba and Piper nigrum in Alzheimer’s Disease–Induced Rats
- Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer’s disease
- Potent Inhibitory Effect of flavonoids in Scutellaria baicalensis on Amyloid β Protein-Induced Neurotoxicity
- Potential application of dietary polyphenols from red wine to attaining healthy ageing
- Potential beneficial effects of a diet with walnuts in aging and Alzheimer’s disease
- Potential complementarity of high-flavanol cocoa powder and spirulina for health protection
- Potential for brain accessibility and analysis of stability of selected flavonoids in relation to neuroprotection in vitro
- Potential health benefits of tea polyphenols—a review
- Potential of medicinal plant compounds to targeting Tau protein in the therapy of Alzheimer’s disease–A review
- Potential of South African medicinal plants targeting the reduction of Aβ42 protein as a treatment of Alzheimer’s disease
- Potential protection of green tea polyphenols against 1800 MHz electromagnetic radiation-induced injury on rat cortical neurons
- Potential role of (-)-epigallocatechin-3-gallate (EGCG) in the secondary prevention of Alzheimer disease
- Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease
- Potential role of olive oil phenolic compounds in the prevention of Neurodegenerative diseases
- Potential Role of Vitamin C in the Prevention of Alzheimer’s Disease
- Potential therapeutic strategies for Alzheimer’s disease targeting or beyond β-amyloid: insights from clinical trials
- Potential therapeutic strategies to prevent the progression of alzheimer to disease states
- Precautionary Ellagic Acid Treatment Ameliorates Chronically Administered Scopolamine Induced Alzheimer’s Type Memory and Cognitive Dysfunctions in …
- Preclinical and potential applications of common western herbal supplements as complementary treatment in Parkinson’s disease
- Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer’s disease
- Prediction of Anti‐Alzheimer’s Activity of flavonoids Targeting Acetylcholinesterase in silico
- Prenylated flavonoids from the Roots of Sophora flavescens Promote Vascular Relaxation via Endothelium-Dependent Mechansims
- Pretreatment with natural flavones and neuronal cell survival after oxidative stress: a structure− activity relationship study
- Prevention and reversal of Alzheimer’s disease: treatment protocol
- Prevention and treatment of Alzheimer disease and aging: antioxidants
- Prevention of Dementia
- Prevention of oxidative injury by flavonoids from stems and leaves of Scutellaria Baicalensis georgi in PC12 cells
- Preventive and Therapeutic Effects of Traditional Medicines on Diabetic Complications: Sophora flavescens, Pueraria lobata, Coptis chinensis, Cirsium …
- Preventive effect of small-leaved kuding tea (Ligustrum robustum (Roxb.) Bl.) polyphenols on D-galactose-induced oxidative stress and aging in mice
- PREVENTIVE EFFECTS OF GREEN TEA CATECHINS ON DEMENTIA
- Primary Prevention of Alzheimer’s Disease (AD)
- Processing of the β‐amyloid precursor protein and its regulation in Alzheimer’s disease
- Profiling of in vitro neurobiological effects and phenolic acids of selected endemic Salvia species
- Progress in drug development for Alzheimer’s disease: an overview in relation to mitochondrial energy metabolism
- Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset.
- Proposed Mechanism of Alzheimer’s Disease: the Role of oxidative stress A Review of Scientific Literature
- Prospective associations between single foods, Alzheimer’s dementia and memory decline in the elderly
- Protection of Okadaic Acid-induced Tau Hyperphosphorylation by Bioflavonoids in Neuroblastoma Cells
- Protective effect of a (poly) phenol-rich extract derived from sweet cherries culls against oxidative cell damage
- Protective effect of a phenolic‐rich fraction from Schisandra chinensis against H2O2‐induced apoptosis in SH‐SY5Y cells
- Protective effect of black tea extract against aluminium chloride-induced Alzheimer’s disease in rats: A behavioural, biochemical and molecular approach
- Protective effect of daidzein against streptozotocin‐induced Alzheimer’s disease via improving cognitive dysfunction and oxidative stress in rat model
- Protective effect of ginger (Zingiber officinale) on Alzheimer’s disease induced in rats
- Protective Effect of Green Tea Extract on Neuronal Cell Death in Alzheimer Model using -amyloid Peptide
- Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils
- Protective effect of iris germanica l. In β-amyloid-induced animal model of Alzheimer’s disease
- Protective effect of isoflavones from Trifolium pratense on dopaminergic neurons
- Protective effect of kaempferol on the transgenic Drosophila model of Alzheimer’s disease
- Protective effect of mulberry crude extract against nonylphenol-induced thyroid disruption by inhibiting the activity of deiodinase in rats
- Protective effect of naringin, a citrus flavonoid, against colchicine-induced cognitive dysfunction and oxidative damage in rats
- Protective effect of Picrorhiza kurroa on Alzheimer’s disease induced by aluminium chloride in rats
- Protective effect of raisin (currant) against spatial memory impairment and oxidative stress in Alzheimer disease model
- Protective effect of rutin, a polyphenolic flavonoid against haloperidol‐induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical …
- Protective effect of standardized extract of Passiflora incarnata flower in Parkinson’s and Alzheimer’s disease
- Protective Effect of the Leaves of Solanum torvums wartz on Drosophila melanogaster against β-Amyloid Induced Alzheimer Disease
- Protective effects of berry polyphenols against age-related cognitive impairment
- Protective effects of dietary polyphenols in human diseases and mechanisms of action
- Protective effects of fisetin and other berry flavonoids in Parkinson’s disease
- Protective effects of flavonoid baicalein against menadione-induced damage in SK-N-MC cells
- Protective effects of flavonoids against Alzheimer’s disease-related neural dysfunctions
- Protective effects of foods containing flavonoids on age-related cognitive decline
- Protective effects of gingerol on streptozotocin-induced sporadic Alzheimer’s disease: emphasis on inhibition of β-amyloid, COX-2, alpha-, beta-secretases …
- Protective effects of Indian spice curcumin against amyloid-β in Alzheimer’s disease
- Protective effects of Portulaca oleracea against rotenone mediated depletion of glutathione in the striatum of rats as an animal model of Parkinson’s disease
- Protective effects of water extract of propolis on dopaminergic neurons, brain derived neurotrophic factor and stress oxidative factors in the rat model of Parkinson’s …
- Protective role of caffeic acid in an Aβ25-35-induced Alzheimer’s disease model
- Protein drug targets of lavandula angustifolia on treatment of rat Alzheimer’s disease
- Protein folding and aggregation into amyloid: the interference by natural phenolic compounds
- Proteomics in traditional Chinese medicine with an emphasis on Alzheimer’s disease
- Putative role of red wine polyphenols against brain pathology in Alzheimer’s and Parkinson’s disease
- Quercetin enrich diet during the early-middle not middle-late stage of Alzheimer’s disease ameliorates cognitive dysfunction
- Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer’s disease
- Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution
- Rational approach to discover multipotent anti-Alzheimer drugs
- Rational Design, Preparation, and Analysis of Chemical Reagents for Investigating Multiple Pathological Factors in Alzheimer’s Disease
- Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson’s disease
- Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region
- Recent advances from metabolomics and lipidomics application in Alzheimer’s disease inspiring drug discovery
- Recent advances in health promoting effect of dietary polyphenols
- Recent advances in herbal medicines treating Parkinson’s disease
- Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present)
- Recent Advances in Nanoencapsulation Systems Using PLGA of Bioactive Phenolics for Protection against Chronic Diseases
- Recent advances in the antioxidant therapies for Alzheimer’s disease: Emphasis on natural antioxidants
- Recent advances in the design and applications of amyloid-β peptide aggregation inhibitors for Alzheimer’s disease therapy
- Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer’s?
- Recent advances in the genetics of Parkinson’s disease
- Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer’s disease
- Recent Expansions on Cellular Models to Uncover the Scientific Barriers Towards Drug Development for Alzheimer’s Disease
- Recent findings in Alzheimer disease and nutrition focusing on epigenetics
- Recent Plant Based Remedies for Alzheimer’s Disease, Parkinson’s Disease and Cerebral Ischemic Stroke
- Recent progress in multifunctional metal chelators as potential drugs for Alzheimer’s disease
- Recent Studies on Mechanisms of New Drug Candidates for Alzheimer’s Disease Interacting with Amyloid-β Protofibrils Using Molecular Dynamics Simulations
- Recent trends in drug discovery against Alzheimer’s disease: use of natural products and nutraceuticals from botanicals
- Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson’s disease
- Recent updates on the association between Alzheimer’s disease and vascular dementia
- Recent Updates on the Association Between Alzheimer’s Disease and Vascular Dementia
- Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers
- Recovery of new diarylheptanoid sources in Betulaceae: Characterisation of the phenolic profile of Corylus species by HPLC-ESI-MS methods
- Recycling acetate for improving flavanones production from Escherichia coli
- Red grape juice and Alzheimer’s disease
- Red wine polyphenol-induced, endothelium-dependent NO-mediated relaxation is due to the redox-sensitive PI3-kinase/Akt-dependent phosphorylation of …
- Red wine retards Abeta deposition and neuroinflammation in Alzheimer’s disease
- Red wine, resveratrol, and Alzheimer’s disease
- Redox chemistry of green tea polyphenols: therapeutic benefits in Neurodegenerative diseases
- Reduction is the New Youth: The Effect of Polyphenols on Brain Aging and Diseases
- Regulation of autophagy by polyphenols: Paving the road for treatment of neurodegeneration
- Relationship between Wine Consumption and Alzheimer’s Disease
- Relationship of Wine Consumption with Alzheimer’s Disease
- Relationships of dietary patterns, foods, and micro-and macronutrients with Alzheimer’s disease and late-life cognitive disorders: a systematic review
- Research Article Improvement of Learning and Memory by Morin, A flavonoid in Young and Aged Mice
- Research of polyphenols with neuroprotective potential in a yeast model of degeneration
- Restoration of stressor-induced calcium dysregulation and autophagy inhibition by polyphenol-rich açaí (Euterpe spp.) fruit pulp extracts in rodent brain cells in vitro
- Resveratrol and Grape’s Extract-Loaded Solid Lipid Nanoparticles for the Treatment of Parkinson’s and Alzheimer’s Diseases
- Resveratrol as a potential therapeutic candidate for the treatment and management of Alzheimer’s disease
- Resveratrol—a boon for treating Alzheimer’s disease?
- Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia
- Reverse Alzheimer’s Disease Naturally: Alternative Treatments for dementia including Alzheimer’s Disease
- Review of natural products on Parkinson’s disease pathology
- Review of Traditional and Natural Methods of Treating Alzheimer’s Disease
- REVIEW ON CURRENT TREATMENT STRATEGY IN Alzheimer’s DISEASE AND ROLE OF HERBS IN TREATING NEUROLOGICAL DISORDERS
- Review on potential phytocompounds in drug development for Parkinson disease: a pharmacoinformatic approach
- Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective
- Rhodiola rosea L. and Alzheimer’s Disease: From Farm to Pharmacy
- Rhodiola rosea L.-An evaluation of safety and efficacy in the context of a neurological disorder, Alzheimer Disease
- Role of Acetylcholinesterase Inhibitors and Alzheimer Disease
- Role of alpha-synuclein primary structure and oxidative stressin Parkinson’s disease pathology
- Role of amyloid-β–metal interactions in Alzheimer’s disease
- Role of flavonoids in Neurodegenerative Disorders with Special Emphasis on Tangeritin
- Role of flavonoids in oxidative stress
- ROLE OF HESPERETIN & PYRIDOXINE PROTECT IN THE NIGROSTRIATAL DOPAMINERGIC PROJECTION IN A NEUROTOXIN MODEL OF PARKINSON’S
- Role of intestinal microbiota in the generation of polyphenol‐derived phenolic acid mediated attenuation of Alzheimer’s disease β‐amyloid oligomerization
- Role of medicinal plants against Alzheimer’s disease
- Role of medicinal plants in Neurodegenerative diseases with special emphasis to alzheimer’s
- Role of nanomedicines in delivery of anti-acetylcholinesterase compounds to the brain in Alzheimer’s disease
- Role of Nutraceuticals in Alzheimer’s disease
- Role of p38/MAPKs in Alzheimer’s disease: implications for amyloid beta toxicity targeted therapy
- Role of plant polyphenols in Alzheimer’s disease
- Role of plant-derived flavonoids and their mechanism in attenuation of Alzheimer’s and Parkinson’s diseases: An update of recent data
- Role of polyphenols in cell death control
- Role of Polyphenols in the prevention of neurodegeneration
- Role of sirtuins and calorie restriction in neuroprotection: implications in Alzheimer’s and Parkinson’s diseases
- Role of standardized grape polyphenol preparation as a novel treatment to improve synaptic plasticity through attenuation of features of metabolic syndrome in a …
- Role of the APP non-amyloidogenic signaling pathway and targeting α-secretase as an alternative drug target for treatment of Alzheimer’s disease
- Role of the Microbiome in polyphenol Metabolite-Mediated Attenuation of β-amyloid and tau Protein Misfolding in Alzheimer’s Disease
- Roles of AMP-activated protein kinase in Alzheimer’s disease
- Rosmarinic acid suppresses Alzheimer’s disease development by reducing amyloid β aggregation by increasing monoamine secretion
- Roundoc Rx: Neurodegenerative Disease: Part 2—Top Herbs and Supplements for Addressing Alzheimer’s and Parkinson’s Disease
- Rutin as a natural therapy for Alzheimer’s disease: Insights into its mechanisms of action
- Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson’s disease
- Screening and evaluation of natural compounds for therapeutic application in Alzheimer’s disease
- Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer’s disease and in other Neurodegenerative diseases
- Secretase inhibitors for the treatment of Alzheimer’s disease: Long road ahead
- Secretory phospholipase A2-IIA in Alzheimer’s disease and inflammatory responses in astrocytes
- Selective increase of iron in substantia nigra zona compacta of parkinsonian brains
- Separations with Raman Spectroscopy for Identification of Oxidatively Modified Components in Parkinson’s Disease
- Serum concentrations of vitamin E and carotenoids are altered in Alzheimer’s disease: A case-control study
- Several targets involved in Alzheimer’s disease amyloidogenesis are affected by morin and isoquercitrin
- Shaping the Nrf2-ARE-related pathways in Alzheimer’s and Parkinson’s diseases
- Short-term dietary supplementation of blueberry polyphenolics: beneficial effects on aging brain performance and peripheral tissue function
- Short-term dietary supplementation of blueberry polyphenolics: beneficial effects on aging brain performance and peripheral tissue function
- Signal transduction in Alzheimer disease: p21‐activated kinase signaling requires C‐terminal cleavage of APP at Asp664
- Signaling pathway cross talk in Alzheimer’s disease
- Significant roles of neuroinflammation in Parkinson’s disease: therapeutic targets for PD prevention
- Silymarin attenuated the amyloid β plaque burden and improved behavioral abnormalities in an Alzheimer’s disease mouse model
- Silymarin’s inhibition and treatment effects for Alzheimer’s disease
- Simple In Vivo Models of Alzheimer’s Disease
- Simultaneous determination of phenolic compounds in Catharanthus roseus leaves by HPLC method
- Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases
- Sir-2.1 mediated attenuation of α-synuclein expression by Alaskan bog blueberry polyphenols in a transgenic model of Caenorhabditis elegans
- Sirtuins as novel targets for Alzheimer’s disease and other Neurodegenerative disorders: experimental and genetic evidence
- Sirtuins in Alzheimer’s disease: SIRT2-related genophenotypes and implications for pharmacoepigenetics
- Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues
- Small molecule natural products and Alzheimer’s disease
- Sophora Tomentosa Extract Prevents MPTP-Induced Parkinsonism in C57BL/6 Mice Via the Inhibition of GSK-3β Phosphorylation and Oxidative Stress
- Spices And Herbs: An Essential Guide To Spice Up Your Health And Flavor Your Diet
- ß-Amyloid and oxidative stress in the Pathogenesis of Alzheimer’s Disease
- Stahl’s Illustrated Alzheimer’s Disease and Other Dementias
- Statistical and Data Mining Methodologies for Behavioral Analysis in Transgenic Mouse Models of Alzheimer’s Disease: Parallels with Human AD Evaluation
- Stem Cell Biology for Therapeutic Development in Parkinson’s Disease
- STEM CELL-BASED THERAPY FOR Alzheimer’s DISEASE
- Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer’s Disease
- Strategies for Multi-target Directed Ligands: Application in Alzheimer’s Disease (AD) Therapeutics
- Structural Analysis of Flavonoid/Drug Target Complexes: Natural Products as Lead Compounds for Drug Development
- Structural Elucidation of Novel Phenolic Glycosides in Cimicifugae Rhizoma by Structure-based Chemical Screening using LC-NMR and LC-UV-MS
- Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity
- Structure-activity relationships of flavonoids
- Structure–activity relationships of acetylated flavone glycosides from Galeopsis ladanum L.(Lamiaceae)
- Studies on Amyloid Beta Peptide Aggregation and Its Modulation by Garlic Components: Relevance to Alzheimer’s Disease
- Studies on the Leaves of Punica Granatum Linn. and its Invitro Inhibition of Ache for Potential Use in Alzheimer’s Treatment
- Study of oxidative stress and Alzheimer’s disease in transgenic mice and pharmacological agents to counteract nutritional deficiency
- Study of Possible neuroprotective Effects of Certain Drugs on Experimentally Induced Parkinson’s Disease in Rats
- Study on neuroprotective capacity of key flavonoids of ampelopsis grossedentata
- Sub-critical solvent extraction of flavonoid-rich grape by-products
- Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer’s Disease: A Systematic Review
- Supplementation with vitamins E plus C or soy isoflavones in ovariectomized rats: effect on the activities of Na+, K+-ATPase and cholinesterases
- Suppression of presymptomatic oxidative stress and inflammation in neurodegeneration by grape-derived polyphenols
- Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity
- Sweet Cherry Phenolic Compounds: Identification, Characterization, and Health Benefits
- Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease
- Synergistic action of melatonin in combination with Anti-Parkinsonian drugs in experimental model of parkinson s disease
- Synergistic antioxidant action of vitamin E and rutin SNEDDS in ameliorating oxidative stress in a Parkinson’s disease model
- Synergistic Effect of Selected Hydroxy Cinnamic Acid Derivative (HCA) With Rivastigmine in Dementia
- Synergistic neuroprotective effects of Withania somnifera with specific dietary derived polyphenols
- Synergistic properties of bioavailable phenolic compounds from olive oil: electron transfer and neuroprotective properties
- Synthesis and antioxidant activity of phenolic amides
- Synthesis and biological evaluation of novel homoisoflavonoids for retinal neovascularization
- Synthesis and Development of BACE 1 Inhibitor for Alzheimer’s Diseases from Medicinal Plants
- Synthesis and evaluation of neuroprotective selenoflavanones
- Synthesis of Isooctyl Phenol Analogs from Insect-Flower
- Synthesis of phenolic amides and evaluation of their antioxidant and anti-inflammatory activity in vitro and in vivo
- Systems pharmacology based approach to investigate the in-vivo therapeutic efficacy of Albizia lebbeck (L.) in experimental model of Parkinson’s disease
- T lymphocytes and inflammatory mediators in the interplay between brain and blood in Alzheimer’s disease: potential pools of new biomarkers
- Target-based selection of flavonoids for Neurodegenerative disorders
- Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
- Targeting dysregulation of brain iron homeostasis in Parkinson’s disease by iron chelators
- Targeting ERK signaling pathway by polyphenols as novel therapeutic strategy for neurodegeneration
- Targeting Inflammatory Pathways in Alzheimer’s Disease: A Focus on Natural Products and Phytomedicines
- Targeting miRNAs by polyphenols: novel therapeutic strategy for aging
- Targeting multiple Alzheimer’s disease etiologies with multimodal neuroprotective and neurorestorative iron chelators
- Targeting NADPH Oxidase and Phospholipases A2 in Alzheimer’s Disease
- Targeting Parkinson’s-tyrosine hydroxylase and oxidative stress as points of interventions
- Targeting the Nrf2/amyloid-beta liaison in Alzheimer’s disease: A rational approach
- Targeting the progression of Parkinson’s disease
- Targeting α-synuclein aggregation for Parkinson’s disease treatment
- Targeting α-Synuclein as a Parkinson’s Disease Therapeutic
- Tau-based therapies for Alzheimer’s disease: Promising novel neuroprotective approaches
- Tea and Parkinson’s disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits
- Tea flavonoids and their effect on chronic inflammation induced in Trypanosoma brucei brucei infected mice
- Tea-Derived Polyphenols and Stilbenes on Amyloid Neurotoxicity
- The ability of three African herbal remedies to offer protection against an in vitro model of Parkinson’s disease
- The action of polyphenols in diabetes mellitus and Alzheimer’s disease: A common agent for overlapping pathologies
- The Alzheimer’s Prevention Cookbook: 100 Recipes to Boost Brain Health
- The amyloid beta peptide: a chemist’s perspective. Role in Alzheimer’s and fibrillization
- The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal
- The anti-amyloidogenic effect is exerted against Alzheimer’s β-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure
- The Antimicrobial Activity Mechanism of Sophoraflavanone B against Methicillin-Resistant Staphylococcus aureus
- The antioxidant properties of 4–quinolones compared to structurally related flavonoids
- The Association Between Dietary flavonoid Intake and Chronic Obstructive Pulmonary Disease, Systemic Inflammation, and Comorbidity Burden
- The beneficial and deleterious role of dietary polyphenols on chronic degenerative diseases by regulating gene expression
- The beneficial effects of dietary flavonoids: Sources, bioavailability and biological functions
- The beneficial effects of fruit polyphenols on brain aging
- The beneficial role of Naringin-a citrus bioflavonoid, against oxidative stress-induced neurobehavioral disorders and cognitive dysfunction in rodents: A systematic …
- THE BENEFITS OF RESVERATROL WITH POLYPHENOLS IN Parkinson’s DISEASE WITH Alzheimer’s CHANGES
- The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson’s disease
- The cascade of oxidative stress and tau protein autophagic dysfunction in Alzheimer’s disease
- The Change of Neurotransmitters in Plasma of dementia Patients after Aromatherapy.
- The Crocus sativus compounds trans-crocin 4 and trans-crocetin modulate the amyloidogenic pathway and tau misprocessing in Alzheimer disease neuronal cell …
- The development of preventives and therapeutics for Alzheimer’s disease that inhibit the formation of β-amyloid fibrils (fAβ), as well as destabilize preformed fAβ
- The Effect of Essential Oil on Plasma Level of 5-HT in dementia Patients
- The effect of Ginkgo biloba extract on parkinsonisminduced biochemical changes in brain of irradiated rats
- The effect of green tea consumption on oxidative stress markers and cognitive function in patients with Alzheimer’s disease: A prospective intervention study
- The effect of polyphenols on protein degradation pathways: implications for neuroprotection
- The effect of Scutellaria baicalensis stem-leaf flavonoids on spatial learning and memory in chronic cerebral ischemia-induced vascular dementia of rats
- The effects of flavonoid and other polyphenol consumption on cognitive performance: a systematic research review of human experimental and epidemiological …
- The effects of the flavonoid baicalein and osmolytes on the Mg 2+ accelerated aggregation/fibrillation of carboxymethylated bovine 1SS-α-lactalbumin
- The Effects of the Green Tea polyphenol Epigallocatechin Gallate on the Central Nervous, Endocrine, and Innate Immune Systems
- The epidemiology of Parkinson’s disease: risk factors and prevention
- The flavanol (−)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against …
- The flavone luteolin improves central nervous system disorders by different mechanisms: a review
- The flavonoid baicalein promotes NMDA receptor‐dependent long‐term potentiation and enhances memory
- The flavonoid Derivative 2-(4′ Benzyloxyphenyl)-3-hydroxy-
chromen-4-one Protects Against Aβ42-Induced Neurodegeneration in Transgenic Drosophila: Insights … - The flavonoid quercetin ameliorates Alzheimer’s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer’s disease model …
- The flavonoids ameliorates: protective mechanisms in Neurodegenerative diseases
- The GC-MS analyses of the n-hexane extract of Nitraria schoberi L., its total phenolics and in vitro antioxidant activity
- The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide‐induced toxicity: involvement of its flavonoid constituents and protein …
- The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide‐induced toxicity: involvement of its flavonoid constituents and protein …
- The Ginkgo biloba extract EGb 761® and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex
- The gut microbiota links dietary polyphenols with management of psychiatric mood disorders
- The Healthy Mind Cookbook: Big-flavor Recipes to Enhance Brain Function, Mood, Memory, and Mental Clarity
- The immunomodulatory and anti-inflammatory role of polyphenols
- The impact of flavonoids on memory: physiological and molecular considerations
- The impact of fruit flavonoids on memory and cognition
- The impact of gastrointestinal modifications, blood-brain barrier transport, and intracellular metabolism on polyphenol bioavailability: an overview
- The influence of beverage composition on delivery of phenolic compounds from coffee and tea
- The influence of common free radicals and antioxidants on development of Alzheimer’s Disease
- The influence of oxidative stress in Alzheimer’s disease-possible beneficial relevance of the antioxidants from wheatgrass juice. Review Article
- The influence of plant extracts on Ȼ Amyloid induced pathologies in an APP/PS1 mouse model of Alzheimer’s disease
- The interactions of flavonoids within neuronal signalling pathways
- The mechanisms of action of flavonoids in the brain: direct versus indirect effects
- The medicinal chemistry of natural and semisynthetic compounds against Parkinson’s and Huntington’s diseases
- The Mind Diet: A Scientific Approach to Enhancing Brain Function and Helping Prevent Alzheimer’s and Dementia
- The molecular basis of the prevention of Alzheimer’s disease through healthy nutrition
- The molecular basis of working mechanism of natural polyphenolic antioxidants
- The n-Butanol Fraction and Rutin from Tartary Buckwheat Improve Cognition and Memory in an In Vivo Model of Amyloid-β-Induced Alzheimer’s Disease
- The neuroprotective effect and action mechanism of polyphenols in diabetes mellitus-related cognitive dysfunction
- The neuroprotective effects of cocoa flavanol and its influence on cognitive performance
- The neuroprotective potential of flavonoids: a multiplicity of effects
- The neuroprotective potential of phenolic-enriched fractions from four Juniperus species found in Portugal
- The Nrf2/HO-1 Axis as Targets for Flavanones: Neuroprotection by Pinocembrin, Naringenin, and Eriodictyol
- The Nutritional Components of Beer and Its Relationship with Neurodegeneration and Alzheimer’s Disease
- The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer’s disease
- The oxidative stress hypothesis in Alzheimer’s disease
- The potential of flavonoids for the treatment of Neurodegenerative diseases
- The potential role of dietary polyphenols in Parkinson’s disease
- The prenylflavonoid xanthohumol reduces Alzheimer-like changes and modulates multiple pathogenic molecular pathways in the neuro2a/APPswe cell …
- The present and future of pharmacotherapy of Alzheimer’s disease: A comprehensive review
- The protective role of plant biophenols in mechanisms of Alzheimer’s disease
- The relevance body mass index on the oxidative stress status of Alzheimer’s disease pathology
- The role of dietary coconut for the prevention and treatment of Alzheimer’s disease: potential mechanisms of action
- The Role of HIV-1 Proteins in Alzheimer’s Disease Pathology
- The role of iron-induced fibrin in the pathogenesis of Alzheimer’s disease and the protective role of magnesium
- The role of lifestyle factors in cognitive aging and dementia
- The role of lipids and membranes in the pathogenesis of Alzheimer’s disease: a comprehensive view
- The role of natural products in Alzheimer’s and Parkinson’s disease
- The role of natural products in the discovery of new drug candidates for the treatment of Neurodegenerative disorders II: Alzheimer’s disease
- The role of nutrient-based epigenetic changes in buffering against stress, aging, and Alzheimer’s disease
- The role of nutrition in the prevention and treatment of dementia
- The Role of oxidative stress and Cholesterol in Animal Models of Alzheimer’s Disease
- The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation …
- The role of phytochemicals in the treatment and prevention of dementia
- The role of polyphenolic antioxidants in health, disease, and aging
- The role of polyphenols in the modulation of sirtuins and other pathways involved in Alzheimer’s disease
- The role of reactive oxygen species in the pathogenesis of Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: a mini review
- The role of rutin and diosmin, two citrus polyhydroxyflavones in disease prevention and treatment
- The role of the ubiquitin proteasome system in Alzheimer’s disease
- The Safe and Effective Applications of Essential Oils in Alzheimer’s Dementia
- The science of cocoa flavanols: bioavailability, emerging evidence, and proposed mechanisms
- The Simplicity of dementia A Guide for Family and Carers
- The Structural Hybrids of Acetylcholines-terase Inhibitors in the Treatment of Alzheimer’s Disease: A Review
- The therapeutic potential of rosemary (Rosmarinus officinalis) diterpenes for Alzheimer’s disease
- The Therapeutic Role of Turmeric in Treatment and Prevention of Alzheimer’s Disease
- The therapeutical potential of alpha-synuclein antiaggregatory agents for dementia with Lewy bodies
- The Treatment of Brain Inflammation in Alzheimer’s Disease. Can Traditional Medicines Help?
- The use of cell-free systems to characterize Parkinson’s disease-related gene products
- The use of flavonoids in central nervous system disorders
- The use of herbal medicine in Alzheimer’s disease—a systematic review
- The Use of herbal supplements on minimizing the clinical manifestations of Alzheimer’s disease
- The Use of Polyphenols for the Treatment of Alzheimer’s Disease
- Therapeutic Advancement in Alzheimer Disease: New Hopes on the Horizon?
- Therapeutic agents in Alzheimer’s disease through a multi-targetdirected ligands strategy: recent progress based on tacrine core
- Therapeutic approaches to Alzheimer’s disease through stimulating of non-amyloidogenic processing of amyloid precursor protein
- Therapeutic attenuation of neuroinflammation and apoptosis by black tea theaflavin in chronic MPTP/probenecid model of Parkinson’s disease
- Therapeutic effect of modulating TREM-1 via anti-inflammation and autophagy in Parkinson’s disease
- Therapeutic effects of Cyperus rotundus rhizome extract on memory impairment, neurogenesis and mitochondria in beta-amyloid rat model of Alzheimer’s disease
- Therapeutic impact of grape leaves polyphenols on certain biochemical and neurological markers in AlCl3-induced Alzheimer’s disease
- Therapeutic implications of anti-inflammatory natural products in Alzheimer’s disease
- Therapeutic interventions for the suppression of Alzheimer’s disease: quest for a remedy
- Therapeutic potential of baicalein in Alzheimer’s disease and Parkinson’s disease
- Therapeutic Potential Of Catechins And Derivatives For The Prevention Of Alzheimer’s
- Therapeutic Potential Of Catechins And Derivatives For The Prevention Of Alzheimer’s Disease
- Therapeutic potential of luteolin in transgenic Drosophila model of Alzheimer’s disease
- Therapeutic potential of natural products in Parkinson’s disease
- Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed)
- Therapeutic Potential of Polyphenols in Parkinson’s Disease
- Therapeutic potentials of herbal drugs for Alzheimer’s disease—An overview
- Therapeutic potentials of microalgae in the treatment of Alzheimer’s disease
- Therapeutic potentials of plant iridoids in Alzheimer’s and Parkinson’s diseases: A review
- Therapeutic role of sirtuins in Neurodegenerative disease and their modulation by polyphenols
- Therapeutic strategies targeting amyloid-β in Alzheimer’s disease
- Therapeutics of Alzheimer’s disease: Past, present and future
- Therapies for Parkinson’s diseases: alternatives to current pharmacological interventions
- Therapies for prevention and treatment of Alzheimer’s disease
- Thymus pulegioides L. as a rich source of antioxidant, anti-proliferative and neuroprotective phenolic compounds
- Tissue injury by reactive oxygen species and the protective effects of flavonoids
- To Study The Ameliorative Effect Of Hydroalcholic Extract Of Caryota urens (Arecaceae) On Streptozotocin Induced Alzheimer’s Model In Mice
- Tomato (Lycopersicon esculentum) seeds: new flavonols and cytotoxic effect
- Tools of the trade: investigations into design strategies of small molecules to target components in Alzheimer’s disease
- Total and specific polyphenol intakes in midlife are associated with cognitive function measured 13 years later
- Total Phenolic and flavonoid Content and Biological Activities of Extracts and Isolated Compounds of Cytisus villosus Pourr.
- Total Phenolic, Flavonoid, Fatty Acid Contents and Cytotoxic, Antioxidant, and Antimicrobial Activities of Hedysarum aucheri
- Total Synthesis of an C-CH2-C Linked Ochnaflavone
- Total Synthesis of Ochnaflavone Analogs Having CNH-C and CSC Linkages
- Total Synthesis of Ochnaflavone, A Potent Plant-originated Biflavonoid with Anti-inflammatory Activity
- Towards a bioinformatics analysis of anti-Alzheimer’s herbal medicines from a target network perspective
- Toxic exposure and life style factors on ageing brain Neurodegenerative disease, Alzheimer’s and Parkinson’s: Role of natural antioxidants to ameliorate the condition
- Traditional and modern medicine harmonizing the two approaches in the treatment of neurodegeneration (Alzheimer’s disease-AD)
- Traditional Chinese medicines and Alzheimer’s disease
- Traditional Medicine in the Treatment of dementia and Alzheimer’s Disease
- Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
- Transthyretin chemical chaperoning by flavonoids: Structure–activity insights towards the design of potent amyloidosis inhibitors
- Treatment of Alzheimer Disease with Phytochemicals Other Than Curcumin
- Treatment of inflammatory bowel disease via green tea polyphenols: Possible application and protective approaches
- Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson’s disease: Possible involvement of PI3K/ERβ signaling
- Type 2 diabetes mellitus and Alzheimer’s disease: bridging the pathophysiology and management
- Tyrosol Reduces Amyloid-β Oligomer Neurotoxicity and Alleviates Synaptic, Oxidative, and Cognitive Disturbances in Alzheimer’s Disease Model Mice
- Ulmosides A: flavonoid 6-C-glycosides from Ulmus wallichiana attenuates lipopolysacchride induced oxidative stress, apoptosis and neuronal death
- Understanding Alzheimer’s Disease and Other Dementias
- UNDERSTANDING PHYTOTHERAPY OF Alzheimer’s DISEASE: LAST DECADE AND COMING FUTURE
- Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and Neurodegenerative diseases
- Unique properties of polyphenol stilbenes in the brain: more than direct antioxidant actions; gene/protein regulatory activity
- Use of Herbal Products/Alternative Medicines in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease)
- Validation of neuroprotective action of a commercially available formulation of olive polyphenols in a zebra-fish model vis-a-vis pure hydroxytyrosol
- Vanillin attenuated behavioural impairments, neurochemical deficts, oxidative stress and apoptosis against rotenone induced rat model of Parkinson’s disease
- Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer’s disease: a new approach to therapy
- VISCUM ALBUM ENHANCES BLOOD SERUM BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) LEVEL IN EXPERIMENTAL MODEL OF Alzheimer’s …
- Walnut supplementation in the diet reduces oxidative damage and improves antioxidant status in transgenic mouse model of Alzheimer’s disease
- What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research
- Whole-food diet worsened cognitive dysfunction in an Alzheimer’s disease mouse model
- Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson’s and Alzheimer’s disorders?
- Wine consumption, cognitive function and dementias–A relationship?
- Wine flavonoids in health and disease prevention
- Wine phenolics
- Wine Polyphenols and Neurodegenerative Diseases: An Update on the Molecular Mechanisms Underpinning Their Protective Effects
- Wine polyphenols: potential agents in neuroprotection
- Wine-Derived Phenolic Metabolites in the Digestive and Brain Function
- Withanolides: biologically active constituents in the treatment of Alzheimer’s disease
- Xanthone and flavone derivatives as dual agents with acetylcholinesterase inhibition and antioxidant activity as potential anti-alzheimer agents
- Xenobiotic metabolism and berry flavonoid transport across the blood− brain barrier
- Zingiber officinale and Alzheimer’s disease: evidences and mechanisms
- α-Synuclein Aggregation and Parkinson’s Disease
- α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson’s disease
- α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesis
- α-Synuclein misfolding and Parkinson’s disease
- α‐Synuclein oligomers and clinical implications for Parkinson disease
- β-Synuclein Assembly as a Therapeutic Target of Parkinson’s Disease and Related Disorders
- … -DAD Fingerprinting Analysis, Antioxidant Activity of Phenolic Extracts from Blighia sapida Bark and Its Inhibition of Cholinergic Enzymes Linked to Alzheimer’s …
- … -rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine rat model of Parkinson’s disease - … , Biological Evaluation And Molecular Modeling Studies Of Novel Multifunctional neuroprotective Drugs For The Treatment Of Parkinson’s Disease: An Effort …
- … , α-Glucosidase, Pancreatic Lipase, Acetyl-and Butyrylcholinesterase Inhibition Activity of Chaenomeles Fruits Determined by Polyphenols and other Chemical …
- … acid and E. resveratroloside act as potential plant derived compounds against dopamine receptor D3 for Parkinson’s disease: a pharmacoinformatics study
- … and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson’s disease with dementia
- … and antioxidant potentials of a medicinal plant Abroma augusta: Implications for the alternative treatment therapy of cognitive deficits in Alzheimer’s disease
- … and their acet